data_5ie8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5ie8 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 282' ' ' ASP . . . . . 0.638 ' CB ' ' HD2' ' A' ' 283' ' ' PRO . 0.3 OUTLIER . . . . . 0 CA--C 1.551 1.011 0 CA-C-O 117.258 -1.353 . . . . 5.71 108.998 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . 0.638 ' HD2' ' CB ' ' A' ' 282' ' ' ASP . 20.5 Cg_exo -12.32 -63.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.377 2.066 1 C-N-CA 126.231 4.621 . . . . 4.8700000000000001 118.006 -175.753 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' TRP . . . . . . . . . . . . . 17.2 p90 -56.65 -42.04 78.26 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.051 0.453 . . . . 6.4900000000000002 111.283 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . 0.608 HH11 ' HB2' ' A' ' 285' ' ' ARG . 0.0 OUTLIER -65.01 -41.71 95.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.854 -0.612 . . . . 4.4400000000000004 110.025 172.263 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' HIS . . . . . 0.422 ' HB3' ' O ' ' A' ' 283' ' ' PRO . 14.2 t-80 -56.46 -36.45 69.06 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.858 -1.065 . . . . 3.29 111.06 -173.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -54.16 -48.61 70.69 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.916 -0.401 . . . . 1.26 109.916 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -57.71 -39.1 76.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.593 -0.73 . . . . 2.0299999999999998 111.636 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 38.3 mtt-85 -88.5 0.76 55.96 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.931 -0.577 . . . . 5.5300000000000002 112.032 -176.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 61.7 m -122.39 -33.68 3.41 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.113 0.412 . . . . 3.23 112.113 -174.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -117.68 129.74 55.91 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.814 -0.355 . . . . 4.79 110.456 -176.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -75.77 132.23 40.3 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.879 -0.601 . . . . 4.71 110.262 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 65.3 mt -73.89 137.13 23.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.275 -0.42 . . . . 6.46 110.318 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 105.14 -7.98 44.67 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.852 -0.689 . . . . 3.0099999999999998 112.861 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -85.85 152.17 23.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.036 0.446 . . . . 2.77 110.728 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 2.3 mp -95.26 120.76 45.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.702 -0.681 . . . . 1.6499999999999999 109.241 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 17.2 t -130.28 135.09 26.89 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.539 -0.301 . . . . 3.02 111.284 -173.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . 0.547 ' HA ' ' HA ' ' A' ' 345' ' ' MET . 24.3 Cg_exo -64.4 123.86 12.45 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.774 2.316 . . . . 2.96 111.791 173.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -123.58 -175.2 14.4 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 111.095 -0.802 . . . . 1.77 111.095 176.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -127.23 111.83 14.4 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.607 0.242 . . . . 2.3599999999999999 110.447 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 61.1 t -71.6 100.72 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.448 -0.575 . . . . 1.8400000000000001 109.448 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' THR . . . . . 0.478 ' O ' HG23 ' A' ' 340' ' ' VAL . 3.4 t -88.07 -44.02 11.26 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.951 -0.568 . . . . 1.24 110.796 -175.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 6.2 ttpp -129.53 160.87 31.87 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-O 120.769 0.318 . . . . 1.97 111.142 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.485 HD13 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -151.48 151.67 31.96 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.173 -0.467 . . . . 2.1499999999999999 111.289 -179.075 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 1.5 m -150.41 154.89 36.34 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 108.714 -0.847 . . . . 1.47 108.714 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.18 -16.58 3.01 Favored 'Trans proline' 0 N--CA 1.479 0.629 0 C-N-CA 123.795 2.997 . . . . 0.84999999999999998 115.319 -169.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -106.96 -16.98 14.31 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.554 0.575 . . . . 1.25 112.554 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 321' ' ' VAL . . . -173.62 160.22 30.34 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.293 -0.956 . . . . 1.1699999999999999 112.959 -176.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' ALA . . . . . 0.598 ' O ' ' HA ' ' A' ' 320' ' ' LEU . . . -123.39 149.06 45.45 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 117.161 0.48 . . . . 1.24 110.58 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' PHE . . . . . 0.414 ' CZ ' HD13 ' A' ' 320' ' ' LEU . 66.5 m-85 -105.21 117.19 33.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.08 0.467 . . . . 1.8200000000000001 111.432 -176.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 3.0 p -104.39 134.96 44.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.686 -0.688 . . . . 1.96 110.253 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -84.5 110.75 18.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.155 -0.475 . . . . 1.6499999999999999 110.105 177.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.415 HG21 HG21 ' A' ' 317' ' ' ILE . 3.8 m -105.54 -42.88 7.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.924 0.392 . . . . 1.3100000000000001 110.919 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -145.63 148.14 32.79 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.182 -1.044 . . . . 1.8200000000000001 108.182 176.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -56.35 115.37 2.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.043 0.449 . . . . 2.6899999999999999 111.637 -173.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 105.99 -19.48 37.95 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.65 -0.705 . . . . 0.94999999999999996 113.166 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.415 HG21 HG21 ' A' ' 313' ' ' VAL . 6.2 tt -117.62 127.65 74.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.655 0.741 . . . . 1.8400000000000001 111.339 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -123.44 133.17 54.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.248 -0.887 . . . . 1.51 110.363 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . 0.565 ' CA ' HG22 ' A' ' 358' ' ' ILE . . . -96.89 124.66 8.19 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.873 -0.68 . . . . 0.73999999999999999 112.303 -175.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.598 ' HA ' ' O ' ' A' ' 309' ' ' ALA . 10.5 tt -91.09 132.35 36.1 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.572 -0.529 . . . . 2.5899999999999999 109.572 178.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . 0.559 ' O ' ' HA2' ' A' ' 308' ' ' GLY . 29.9 m -118.79 114.34 44.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.623 -0.51 . . . . 1.76 109.623 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -59.75 152.14 23.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.128 0.49 . . . . 2.6600000000000001 110.502 -174.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 8.9 tp -53.12 -25.87 10.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.013 -0.994 . . . . 2.3500000000000001 111.94 -177.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 42.4 t -82.89 -25.65 32.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.082 -0.508 . . . . 2.3999999999999999 111.031 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -78.76 -10.93 59.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.15 0.5 . . . . 2.6200000000000001 110.018 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 96.0 mt -79.95 -49.34 12.0 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.567 -0.742 . . . . 2.5 110.682 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -154.94 162.21 41.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.153 0.502 . . . . 2.7799999999999998 111.208 -176.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -84.86 -12.87 52.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.218 -0.901 . . . . 3.3100000000000001 110.737 -175.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' ARG . . . . . 0.537 ' HG2' ' N ' ' A' ' 330' ' ' HIS . 0.0 OUTLIER -105.19 176.59 5.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.118 -0.492 . . . . 2.4300000000000002 110.683 -178.781 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' HIS . . . . . 0.537 ' N ' ' HG2' ' A' ' 329' ' ' ARG . 70.9 t60 -60.57 106.7 0.58 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.93 -0.577 . . . . 2.9900000000000002 111.501 177.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' VAL . . . . . . . . . . . . . 44.3 t -104.99 121.44 56.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.744 -0.835 . . . . 1.95 108.744 170.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -70.87 -59.25 2.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.538 0.685 . . . . 3.8300000000000001 109.982 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 8.6 p -133.06 140.98 39.22 Favored Pre-proline 0 C--N 1.319 -0.733 0 N-CA-C 108.033 -1.099 . . . . 2.5800000000000001 108.033 175.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -43.46 -25.08 0.72 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.925 3.084 . . . . 1.76 114.008 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -53.15 -30.19 35.66 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 123.777 0.673 . . . . 2.1499999999999999 111.753 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -58.14 -40.14 80.59 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 120.955 0.407 . . . . 2.27 110.884 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 38.9 t -102.86 -45.5 10.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.024 -0.535 . . . . 2.6099999999999999 110.344 -174.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.77 118.65 34.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.808 -0.633 . . . . 2.6699999999999999 110.718 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -103.9 169.89 8.24 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.124 -0.489 . . . . 1.9399999999999999 110.188 176.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 302' ' ' THR . 14.3 p -51.17 123.84 3.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.67 -0.695 . . . . 2.8100000000000001 111.086 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 97.86 -2.43 60.13 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.619 -0.801 . . . . 2.1800000000000002 112.917 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -65.74 131.49 46.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.818 0.342 . . . . 1.6000000000000001 110.619 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -107.57 103.6 12.96 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.275 -0.639 . . . . 2.0299999999999998 109.275 178.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -132.09 140.25 48.78 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.685 0.279 . . . . 2.1400000000000001 111.64 -173.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' MET . . . . . 0.547 ' HA ' ' HA ' ' A' ' 298' ' ' PRO . 0.2 OUTLIER -82.48 121.65 27.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.283 0.563 . . . . 3.46 110.307 175.182 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.54 153.68 35.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.468 -0.787 . . . . 2.0 109.484 -177.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -82.44 122.08 27.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.617 0.246 . . . . 2.5099999999999998 110.627 178.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 66.8 t -72.83 105.84 2.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.114 -0.698 . . . . 2.0899999999999999 109.114 172.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' ILE . . . . . 0.414 HG12 ' O ' ' A' ' 359' ' ' SER . 9.9 pt -92.52 -24.79 5.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.078 -0.51 . . . . 1.54 111.323 -175.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -163.21 162.85 25.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.957 0.408 . . . . 1.4399999999999999 110.938 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -137.06 122.26 25.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.457 -0.792 . . . . 2.04 109.298 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' ASP . . . . . 0.721 ' OD2' ' HD3' ' A' ' 355' ' ' ARG . 12.1 t0 -113.0 73.63 0.82 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.028 -0.73 . . . . 3.6499999999999999 109.028 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . 0.495 HD23 ' C ' ' A' ' 353' ' ' LEU . 0.0 OUTLIER -72.71 -12.93 61.21 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.066 -0.97 . . . . 3.0 111.949 -170.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' GLU . . . . . 0.589 ' C ' ' HD2' ' A' ' 355' ' ' ARG . 41.0 mt-10 -87.66 -13.34 42.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.814 0.34 . . . . 3.7999999999999998 110.808 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' ARG . . . . . 0.721 ' HD3' ' OD2' ' A' ' 352' ' ' ASP . 5.8 mpt_? -116.46 2.5 13.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.672 0.749 . . . . 3.9199999999999999 109.103 174.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . 0.591 ' HG2' HH11 ' A' ' 356' ' ' ARG . 5.5 mmt-85 61.26 43.09 11.2 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 114.19 -1.368 . . . . 3.5099999999999998 111.09 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' ARG . . . . . 0.41 ' HB2' ' HB3' ' A' ' 352' ' ' ASP . 53.3 mtp180 -125.43 157.52 36.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.779 -0.646 . . . . 2.8500000000000001 110.423 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.565 HG22 ' CA ' ' A' ' 319' ' ' GLY . 5.0 tt -141.07 143.71 27.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.588 -0.523 . . . . 2.4500000000000002 109.588 174.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.414 ' O ' HG12 ' A' ' 349' ' ' ILE . 55.9 m -113.75 135.65 53.72 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.425 -0.352 . . . . 1.04 111.164 -174.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.475 ' O ' HG12 ' A' ' 321' ' ' VAL . 4.3 mp -145.13 155.46 43.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.237 -0.438 . . . . 1.73 110.08 178.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 44.3 m -143.09 129.63 20.16 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.962 0.41 . . . . 1.74 110.843 176.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.08 -27.45 66.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.946 -0.57 . . . . 2.4900000000000002 110.617 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' LYS . . . . . 0.41 ' H ' ' HG2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -60.48 -52.8 63.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.305 0.574 . . . . 1.6699999999999999 109.837 -179.607 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' GLN . . . . . 0.461 ' HA ' ' HB3' ' A' ' 367' ' ' GLU . 47.7 mt-30 -70.99 -28.09 64.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.229 -0.896 . . . . 2.48 111.47 -178.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -61.07 -41.04 95.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.028 0.442 . . . . 1.3300000000000001 110.558 175.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -78.16 -29.39 48.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.98 -0.555 . . . . 1.7 110.342 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . 0.461 ' HB3' ' HA ' ' A' ' 364' ' ' GLN . 36.5 tt0 -66.99 -44.0 81.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.378 -0.828 . . . . 2.8100000000000001 111.49 -178.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.715 -0.66 . . . . 2.3599999999999999 110.954 -178.575 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 N--CA 1.466 0.336 0 CA-C-O 119.825 -0.131 . . . . 5.71 111.302 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -27.84 -62.73 0.08 OUTLIER 'Trans proline' 0 C--N 1.354 0.83 1 C-N-CA 125.513 4.142 . . . . 4.8700000000000001 115.615 -175.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' TRP . . . . . . . . . . . . . 14.4 p90 -56.19 -43.88 78.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.124 0.487 . . . . 6.4900000000000002 112.121 -177.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.43 -27.81 34.52 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.433 0.635 . . . . 4.4400000000000004 110.072 -178.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -66.74 -46.05 76.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.408 -0.815 . . . . 3.29 110.228 175.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -54.03 -48.61 70.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.088 -0.505 . . . . 1.26 110.632 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -54.63 -41.47 70.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.779 -0.646 . . . . 2.0299999999999998 112.276 -175.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -91.31 -19.75 22.62 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.455 0.539 . . . . 5.5300000000000002 112.455 -177.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 91.7 m -90.43 -31.43 16.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.933 0.397 . . . . 3.23 111.644 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -115.28 163.5 15.59 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.67 0.271 . . . . 4.79 110.521 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -96.96 121.29 38.68 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.14 -0.482 . . . . 4.71 110.977 -175.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 73.8 mt -65.72 119.87 11.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.244 -0.434 . . . . 6.46 109.903 176.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 101.4 7.81 48.15 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.65 -0.786 . . . . 3.0099999999999998 112.154 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -80.94 147.26 30.36 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.991 0.424 . . . . 2.77 110.178 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 67.0 mt -95.65 110.35 24.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.919 -0.771 . . . . 1.6499999999999999 108.919 172.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 3.4 p -132.42 136.65 28.35 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 116.136 -0.484 . . . . 3.02 110.756 -172.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . 0.55 ' HA ' ' HA ' ' A' ' 345' ' ' MET . 17.7 Cg_endo -58.57 122.05 10.99 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.677 2.251 . . . . 2.96 112.274 177.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.463 ' HA3' ' CG1' ' A' ' 311' ' ' VAL . . . -110.97 -170.33 19.26 Favored Glycine 0 N--CA 1.438 -1.189 0 N-CA-C 111.0 -0.84 . . . . 1.77 111.0 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.445 ' HE3' ' HA2' ' A' ' 341' ' ' GLY . 1.9 tmtm? -152.31 112.48 4.05 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.907 0.384 . . . . 2.3599999999999999 109.979 -175.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 60.3 t -70.74 100.48 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.896 -0.593 . . . . 1.8400000000000001 110.554 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 1.8 t -95.38 -16.15 22.55 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.102 0.477 . . . . 1.24 110.829 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' LYS . . . . . 0.419 ' HB3' ' HE3' ' A' ' 303' ' ' LYS . 3.1 mmmt -154.98 141.12 18.46 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.848 -0.615 . . . . 1.97 109.997 -178.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.518 ' N ' HD12 ' A' ' 304' ' ' LEU . 0.0 OUTLIER -134.86 140.19 45.62 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.163 -0.615 . . . . 2.1499999999999999 110.791 173.646 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 27.3 m -132.17 162.78 54.67 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.324 -0.853 . . . . 1.47 109.295 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -49.36 -31.32 22.69 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.428 2.085 . . . . 0.84999999999999998 114.166 -173.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -109.75 18.07 20.58 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.949 0.722 . . . . 1.25 112.949 -175.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . 0.558 ' HA2' ' O ' ' A' ' 321' ' ' VAL . . . 162.57 160.35 11.08 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 119.069 -1.539 . . . . 1.1699999999999999 114.342 176.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 320' ' ' LEU . . . -114.45 123.35 49.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.542 0.211 . . . . 1.24 110.484 178.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -76.72 108.91 10.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.43 0.633 . . . . 1.8200000000000001 111.529 -176.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.463 ' CG1' ' HA3' ' A' ' 299' ' ' GLY . 88.5 t -92.73 116.27 33.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 114.986 -1.006 . . . . 1.96 110.871 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' ARG . . . . . 0.437 ' NH2' ' HA ' ' A' ' 315' ' ' GLU . 13.1 tpt180 -75.97 117.19 17.43 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.359 -0.837 . . . . 1.6499999999999999 109.688 175.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 4.8 m -119.04 -35.73 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.866 0.365 . . . . 1.3100000000000001 111.786 -178.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -148.95 155.74 41.27 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.567 -0.531 . . . . 1.8200000000000001 109.567 -176.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' GLU . . . . . 0.437 ' HA ' ' NH2' ' A' ' 312' ' ' ARG . 10.0 tp10 -58.22 113.24 1.84 Allowed 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.536 0.522 . . . . 2.6899999999999999 110.619 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 105.65 -11.3 46.19 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.75 -0.738 . . . . 0.94999999999999996 113.404 177.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 8.1 tt -130.0 124.86 59.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 117.925 0.863 . . . . 1.8400000000000001 113.243 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -126.35 136.93 53.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.689 -1.141 . . . . 1.51 108.662 170.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . 0.522 ' HA3' ' O ' ' A' ' 358' ' ' ILE . . . -130.97 138.64 10.32 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.129 -1.034 . . . . 0.73999999999999999 112.772 -176.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.479 ' HA ' ' O ' ' A' ' 309' ' ' ALA . 0.0 OUTLIER -80.55 144.31 32.55 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.014 0.435 . . . . 2.5899999999999999 111.223 -177.767 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . 0.558 ' O ' ' HA2' ' A' ' 308' ' ' GLY . 29.3 m -98.0 138.6 22.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.469 -0.937 . . . . 1.76 108.469 172.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -59.27 147.73 34.61 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.947 0.403 . . . . 2.6600000000000001 110.981 -173.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.555 HD11 ' O ' ' A' ' 323' ' ' ILE . 0.0 OUTLIER -61.31 -21.48 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 115.845 -0.616 . . . . 2.3500000000000001 110.095 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 5.1 m -69.76 -20.41 63.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.799 -0.637 . . . . 2.3999999999999999 110.555 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' GLU . . . . . 0.681 ' OE1' ' HG2' ' A' ' 363' ' ' LYS . 65.7 mm-40 -69.78 -15.38 63.11 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.898 -0.592 . . . . 2.6200000000000001 110.513 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.419 HD12 HG12 ' A' ' 323' ' ' ILE . 49.2 mt -86.67 33.88 0.65 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.622 -0.717 . . . . 2.5 110.651 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . 74.77 -175.38 0.14 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.125 -0.943 . . . . 2.7799999999999998 110.56 -177.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -94.02 -0.57 55.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.066 0.46 . . . . 3.3100000000000001 110.891 -171.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' ARG . . . . . 0.466 ' CZ ' HG23 ' A' ' 331' ' ' VAL . 11.5 ptt85 -84.2 -179.71 7.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.203 0.525 . . . . 2.4300000000000002 111.198 -177.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -82.51 112.99 19.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.421 -0.809 . . . . 2.9900000000000002 110.35 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' VAL . . . . . 0.519 HG11 HE21 ' A' ' 336' ' ' GLN . 48.1 t -129.02 123.31 58.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.094 0.474 . . . . 1.95 110.894 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -71.45 -36.09 71.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.636 -0.711 . . . . 3.8300000000000001 111.712 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 7.1 p -160.76 139.64 7.66 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.694 -0.684 . . . . 2.5800000000000001 109.34 -175.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -44.46 -23.69 0.86 Allowed 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 124.121 3.214 . . . . 1.76 113.721 177.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' A' ' 338' ' ' VAL . 30.2 t70 -60.67 -21.29 62.66 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 123.64 0.588 . . . . 2.1499999999999999 111.579 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' GLN . . . . . 0.519 HE21 HG11 ' A' ' 331' ' ' VAL . 10.6 mt-30 -66.48 -32.79 74.38 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.037 0.446 . . . . 2.27 110.62 176.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 52.0 t -103.09 -54.51 6.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.896 -0.593 . . . . 2.6099999999999999 110.673 -173.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 335' ' ' ASP . 33.0 m -116.83 161.76 15.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.896 -0.593 . . . . 2.6699999999999999 110.251 -178.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -124.88 168.4 13.32 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.098 0.475 . . . . 1.9399999999999999 110.482 177.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 8.2 p -57.25 134.35 21.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.207 -0.906 . . . . 2.8100000000000001 109.857 174.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' GLY . . . . . 0.445 ' HA2' ' HE3' ' A' ' 300' ' ' LYS . . . 100.49 -2.47 56.1 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.491 -0.861 . . . . 2.1800000000000002 112.869 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -70.39 124.62 24.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.817 0.342 . . . . 1.6000000000000001 110.977 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -110.33 113.63 26.44 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.363 -0.606 . . . . 2.0299999999999998 109.363 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -146.58 150.36 35.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.521 0.2 . . . . 2.1400000000000001 111.157 -175.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' MET . . . . . 0.55 ' HA ' ' HA ' ' A' ' 298' ' ' PRO . 18.2 ptm -78.79 120.16 23.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.26 0.552 . . . . 3.46 110.517 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.59 151.7 34.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.705 -0.679 . . . . 2.0 109.641 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 360' ' ' LEU . 1.8 ttmt -88.52 125.73 34.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.609 0.242 . . . . 2.5099999999999998 111.181 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 87.0 t -74.71 101.11 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.824 -0.625 . . . . 2.0899999999999999 109.455 173.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 359' ' ' SER . 6.0 pt -92.53 -20.53 6.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.964 -0.562 . . . . 1.54 111.267 -174.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -161.89 161.77 28.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.921 0.391 . . . . 1.4399999999999999 110.717 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 1.3 mm -137.04 117.18 16.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.338 -0.846 . . . . 2.04 109.335 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' ASP . . . . . 0.484 ' HB3' ' HB2' ' A' ' 355' ' ' ARG . 12.1 m-20 -83.59 96.35 8.62 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.296 0.57 . . . . 3.6499999999999999 109.935 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -57.1 -51.87 67.57 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.423 -1.262 . . . . 3.0 110.83 -176.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -90.89 -14.2 32.16 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.062 0.764 . . . . 3.7999999999999998 113.062 -174.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' ARG . . . . . 0.484 ' HB2' ' HB3' ' A' ' 352' ' ' ASP . 2.2 mpt_? -100.04 -1.13 37.73 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.062 -0.655 . . . . 3.9199999999999999 110.699 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . 0.642 ' HD2' ' N ' ' A' ' 356' ' ' ARG . 2.6 mpt_? 52.89 45.97 27.7 Favored 'General case' 0 C--N 1.335 -0.064 0 CA-C-N 115.008 -0.996 . . . . 3.5099999999999998 111.33 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 30.8 mtp180 -130.51 169.07 16.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.683 -0.689 . . . . 2.8500000000000001 110.103 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.522 ' O ' ' HA3' ' A' ' 319' ' ' GLY . 6.5 tt -140.54 136.65 36.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.719 -0.474 . . . . 2.4500000000000002 109.719 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.477 ' O ' HG12 ' A' ' 349' ' ' ILE . 66.8 m -102.49 130.94 49.45 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.476 -0.329 . . . . 1.04 110.558 -177.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.505 ' HA ' ' O ' ' A' ' 347' ' ' LYS . 3.3 mp -139.65 145.51 38.54 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.344 -0.389 . . . . 1.73 110.369 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 53.9 m -131.88 126.78 35.03 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.308 0.575 . . . . 1.74 111.06 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 52.3 mt -68.78 -27.47 65.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.242 -0.89 . . . . 2.4900000000000002 110.759 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' LYS . . . . . 0.681 ' HG2' ' OE1' ' A' ' 325' ' ' GLU . 0.0 OUTLIER -58.86 -44.98 91.17 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.061 0.457 . . . . 1.6699999999999999 109.865 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' GLN . . . . . 0.428 ' HB3' ' HD2' ' A' ' 347' ' ' LYS . 33.1 mm-40 -70.83 -31.5 68.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.555 -0.748 . . . . 2.48 111.431 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -70.11 -32.24 70.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.98 0.419 . . . . 1.3300000000000001 110.704 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -75.54 -28.58 59.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.042 -0.527 . . . . 1.7 110.328 175.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -66.0 -34.27 77.7 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.425 -0.807 . . . . 2.8100000000000001 111.178 -176.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.8 t70 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.578 -0.725 . . . . 2.3599999999999999 110.533 -179.809 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 . . . . . 0 N--CA 1.481 1.076 0 N-CA-C 110.049 -0.352 . . . . 8.7899999999999991 110.049 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 62.18 31.42 17.65 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.681 0.753 . . . . 5.0800000000000001 109.562 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ASP . . . . . 0.638 ' CB ' ' HD2' ' A' ' 283' ' ' PRO . 0.3 OUTLIER -109.36 -170.62 0.2 Allowed Pre-proline 0 CA--C 1.551 1.011 0 CA-C-O 117.258 -1.353 . . . . 5.71 108.998 -177.314 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . 0.638 ' HD2' ' CB ' ' A' ' 282' ' ' ASP . 20.5 Cg_exo -12.32 -63.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.377 2.066 1 C-N-CA 126.231 4.621 . . . . 4.8700000000000001 118.006 -175.753 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' TRP . . . . . . . . . . . . . 17.2 p90 -56.65 -42.04 78.26 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.051 0.453 . . . . 6.4900000000000002 111.283 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . 0.608 HH11 ' HB2' ' A' ' 285' ' ' ARG . 0.0 OUTLIER -65.01 -41.71 95.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.854 -0.612 . . . . 4.4400000000000004 110.025 172.263 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' HIS . . . . . 0.422 ' HB3' ' O ' ' A' ' 283' ' ' PRO . 14.2 t-80 -56.46 -36.45 69.06 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.858 -1.065 . . . . 3.29 111.06 -173.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -54.16 -48.61 70.69 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.916 -0.401 . . . . 1.26 109.916 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -57.71 -39.1 76.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.593 -0.73 . . . . 2.0299999999999998 111.636 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 38.3 mtt-85 -88.5 0.76 55.96 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.931 -0.577 . . . . 5.5300000000000002 112.032 -176.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 61.7 m -122.39 -33.68 3.41 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.113 0.412 . . . . 3.23 112.113 -174.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -117.68 129.74 55.91 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.814 -0.355 . . . . 4.79 110.456 -176.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -75.77 132.23 40.3 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.879 -0.601 . . . . 4.71 110.262 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 65.3 mt -73.89 137.13 23.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.275 -0.42 . . . . 6.46 110.318 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 105.14 -7.98 44.67 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.852 -0.689 . . . . 3.0099999999999998 112.861 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -85.85 152.17 23.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.036 0.446 . . . . 2.77 110.728 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 2.3 mp -95.26 120.76 45.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.702 -0.681 . . . . 1.6499999999999999 109.241 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 17.2 t -130.28 135.09 26.89 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.539 -0.301 . . . . 3.02 111.284 -173.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . 0.547 ' HA ' ' HA ' ' A' ' 345' ' ' MET . 24.3 Cg_exo -64.4 123.86 12.45 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.774 2.316 . . . . 2.96 111.791 173.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -123.58 -175.2 14.4 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 111.095 -0.802 . . . . 1.77 111.095 176.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -127.23 111.83 14.4 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.607 0.242 . . . . 2.3599999999999999 110.447 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 61.1 t -71.6 100.72 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.448 -0.575 . . . . 1.8400000000000001 109.448 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' THR . . . . . 0.478 ' O ' HG23 ' A' ' 340' ' ' VAL . 3.4 t -88.07 -44.02 11.26 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.951 -0.568 . . . . 1.24 110.796 -175.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 6.2 ttpp -129.53 160.87 31.87 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-O 120.769 0.318 . . . . 1.97 111.142 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.485 HD13 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -151.48 151.67 31.96 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.173 -0.467 . . . . 2.1499999999999999 111.289 -179.075 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 1.5 m -150.41 154.89 36.34 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 108.714 -0.847 . . . . 1.47 108.714 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.18 -16.58 3.01 Favored 'Trans proline' 0 N--CA 1.479 0.629 0 C-N-CA 123.795 2.997 . . . . 0.84999999999999998 115.319 -169.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -106.96 -16.98 14.31 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.554 0.575 . . . . 1.25 112.554 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 321' ' ' VAL . . . -173.62 160.22 30.34 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.293 -0.956 . . . . 1.1699999999999999 112.959 -176.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' ALA . . . . . 0.598 ' O ' ' HA ' ' A' ' 320' ' ' LEU . . . -123.39 149.06 45.45 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 117.161 0.48 . . . . 1.24 110.58 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' PHE . . . . . 0.414 ' CZ ' HD13 ' A' ' 320' ' ' LEU . 66.5 m-85 -105.21 117.19 33.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.08 0.467 . . . . 1.8200000000000001 111.432 -176.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 3.0 p -104.39 134.96 44.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.686 -0.688 . . . . 1.96 110.253 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -84.5 110.75 18.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.155 -0.475 . . . . 1.6499999999999999 110.105 177.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.415 HG21 HG21 ' A' ' 317' ' ' ILE . 3.8 m -105.54 -42.88 7.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.924 0.392 . . . . 1.3100000000000001 110.919 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -145.63 148.14 32.79 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.182 -1.044 . . . . 1.8200000000000001 108.182 176.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -56.35 115.37 2.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.043 0.449 . . . . 2.6899999999999999 111.637 -173.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 105.99 -19.48 37.95 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.65 -0.705 . . . . 0.94999999999999996 113.166 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.415 HG21 HG21 ' A' ' 313' ' ' VAL . 6.2 tt -117.62 127.65 74.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.655 0.741 . . . . 1.8400000000000001 111.339 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -123.44 133.17 54.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.248 -0.887 . . . . 1.51 110.363 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . 0.565 ' CA ' HG22 ' A' ' 358' ' ' ILE . . . -96.89 124.66 8.19 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.873 -0.68 . . . . 0.73999999999999999 112.303 -175.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.598 ' HA ' ' O ' ' A' ' 309' ' ' ALA . 10.5 tt -91.09 132.35 36.1 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.572 -0.529 . . . . 2.5899999999999999 109.572 178.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . 0.559 ' O ' ' HA2' ' A' ' 308' ' ' GLY . 29.9 m -118.79 114.34 44.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.623 -0.51 . . . . 1.76 109.623 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -59.75 152.14 23.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.128 0.49 . . . . 2.6600000000000001 110.502 -174.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 8.9 tp -53.12 -25.87 10.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.013 -0.994 . . . . 2.3500000000000001 111.94 -177.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 42.4 t -82.89 -25.65 32.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.082 -0.508 . . . . 2.3999999999999999 111.031 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -78.76 -10.93 59.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.15 0.5 . . . . 2.6200000000000001 110.018 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 96.0 mt -79.95 -49.34 12.0 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.567 -0.742 . . . . 2.5 110.682 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -154.94 162.21 41.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.153 0.502 . . . . 2.7799999999999998 111.208 -176.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -84.86 -12.87 52.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.218 -0.901 . . . . 3.3100000000000001 110.737 -175.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' ARG . . . . . 0.537 ' HG2' ' N ' ' A' ' 330' ' ' HIS . 0.0 OUTLIER -105.19 176.59 5.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.118 -0.492 . . . . 2.4300000000000002 110.683 -178.781 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' HIS . . . . . 0.537 ' N ' ' HG2' ' A' ' 329' ' ' ARG . 70.9 t60 -60.57 106.7 0.58 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.93 -0.577 . . . . 2.9900000000000002 111.501 177.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' VAL . . . . . . . . . . . . . 44.3 t -104.99 121.44 56.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.744 -0.835 . . . . 1.95 108.744 170.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -70.87 -59.25 2.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.538 0.685 . . . . 3.8300000000000001 109.982 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 8.6 p -133.06 140.98 39.22 Favored Pre-proline 0 C--N 1.319 -0.733 0 N-CA-C 108.033 -1.099 . . . . 2.5800000000000001 108.033 175.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -43.46 -25.08 0.72 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.925 3.084 . . . . 1.76 114.008 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -53.15 -30.19 35.66 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 123.777 0.673 . . . . 2.1499999999999999 111.753 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -58.14 -40.14 80.59 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 120.955 0.407 . . . . 2.27 110.884 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 38.9 t -102.86 -45.5 10.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.024 -0.535 . . . . 2.6099999999999999 110.344 -174.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.77 118.65 34.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.808 -0.633 . . . . 2.6699999999999999 110.718 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -103.9 169.89 8.24 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.124 -0.489 . . . . 1.9399999999999999 110.188 176.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 302' ' ' THR . 14.3 p -51.17 123.84 3.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.67 -0.695 . . . . 2.8100000000000001 111.086 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 97.86 -2.43 60.13 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.619 -0.801 . . . . 2.1800000000000002 112.917 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -65.74 131.49 46.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.818 0.342 . . . . 1.6000000000000001 110.619 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -107.57 103.6 12.96 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.275 -0.639 . . . . 2.0299999999999998 109.275 178.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -132.09 140.25 48.78 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.685 0.279 . . . . 2.1400000000000001 111.64 -173.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' MET . . . . . 0.547 ' HA ' ' HA ' ' A' ' 298' ' ' PRO . 0.2 OUTLIER -82.48 121.65 27.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.283 0.563 . . . . 3.46 110.307 175.182 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.54 153.68 35.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.468 -0.787 . . . . 2.0 109.484 -177.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -82.44 122.08 27.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.617 0.246 . . . . 2.5099999999999998 110.627 178.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 66.8 t -72.83 105.84 2.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.114 -0.698 . . . . 2.0899999999999999 109.114 172.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' ILE . . . . . 0.414 HG12 ' O ' ' A' ' 359' ' ' SER . 9.9 pt -92.52 -24.79 5.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.078 -0.51 . . . . 1.54 111.323 -175.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -163.21 162.85 25.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.957 0.408 . . . . 1.4399999999999999 110.938 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -137.06 122.26 25.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.457 -0.792 . . . . 2.04 109.298 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' ASP . . . . . 0.721 ' OD2' ' HD3' ' A' ' 355' ' ' ARG . 12.1 t0 -113.0 73.63 0.82 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.028 -0.73 . . . . 3.6499999999999999 109.028 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . 0.495 HD23 ' C ' ' A' ' 353' ' ' LEU . 0.0 OUTLIER -72.71 -12.93 61.21 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.066 -0.97 . . . . 3.0 111.949 -170.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' GLU . . . . . 0.589 ' C ' ' HD2' ' A' ' 355' ' ' ARG . 41.0 mt-10 -87.66 -13.34 42.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.814 0.34 . . . . 3.7999999999999998 110.808 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' ARG . . . . . 0.721 ' HD3' ' OD2' ' A' ' 352' ' ' ASP . 5.8 mpt_? -116.46 2.5 13.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.672 0.749 . . . . 3.9199999999999999 109.103 174.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . 0.591 ' HG2' HH11 ' A' ' 356' ' ' ARG . 5.5 mmt-85 61.26 43.09 11.2 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 114.19 -1.368 . . . . 3.5099999999999998 111.09 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' ARG . . . . . 0.41 ' HB2' ' HB3' ' A' ' 352' ' ' ASP . 53.3 mtp180 -125.43 157.52 36.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.779 -0.646 . . . . 2.8500000000000001 110.423 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.565 HG22 ' CA ' ' A' ' 319' ' ' GLY . 5.0 tt -141.07 143.71 27.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.588 -0.523 . . . . 2.4500000000000002 109.588 174.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.414 ' O ' HG12 ' A' ' 349' ' ' ILE . 55.9 m -113.75 135.65 53.72 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.425 -0.352 . . . . 1.04 111.164 -174.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.475 ' O ' HG12 ' A' ' 321' ' ' VAL . 4.3 mp -145.13 155.46 43.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.237 -0.438 . . . . 1.73 110.08 178.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 44.3 m -143.09 129.63 20.16 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.962 0.41 . . . . 1.74 110.843 176.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.08 -27.45 66.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.946 -0.57 . . . . 2.4900000000000002 110.617 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' LYS . . . . . 0.41 ' H ' ' HG2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -60.48 -52.8 63.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.305 0.574 . . . . 1.6699999999999999 109.837 -179.607 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . 0.461 ' HA ' ' HB3' ' A' ' 367' ' ' GLU . 47.7 mt-30 -70.99 -28.09 64.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.229 -0.896 . . . . 2.48 111.47 -178.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -61.07 -41.04 95.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.028 0.442 . . . . 1.3300000000000001 110.558 175.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -78.16 -29.39 48.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.98 -0.555 . . . . 1.7 110.342 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . 0.461 ' HB3' ' HA ' ' A' ' 364' ' ' GLN . 36.5 tt0 -66.99 -44.0 81.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.378 -0.828 . . . . 2.8100000000000001 111.49 -178.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.715 -0.66 . . . . 2.3599999999999999 110.954 -178.575 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 121.443 0.639 . . . . 8.7899999999999991 110.016 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' A' ' 286' ' ' HIS . 39.2 mt-10 -100.47 84.21 2.74 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.968 -0.56 . . . . 5.0800000000000001 109.748 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -63.85 151.19 89.74 Favored Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 115.387 -0.824 . . . . 5.71 111.302 -176.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -27.84 -62.73 0.08 OUTLIER 'Trans proline' 0 C--N 1.354 0.83 1 C-N-CA 125.513 4.142 . . . . 4.8700000000000001 115.615 -175.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' TRP . . . . . . . . . . . . . 14.4 p90 -56.19 -43.88 78.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.124 0.487 . . . . 6.4900000000000002 112.121 -177.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.43 -27.81 34.52 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.433 0.635 . . . . 4.4400000000000004 110.072 -178.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' HIS . . . . . 0.448 ' HB2' ' O ' ' A' ' 281' ' ' GLU . 74.0 t60 -66.74 -46.05 76.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.408 -0.815 . . . . 3.29 110.228 175.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -54.03 -48.61 70.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.088 -0.505 . . . . 1.26 110.632 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -54.63 -41.47 70.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.779 -0.646 . . . . 2.0299999999999998 112.276 -175.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -91.31 -19.75 22.62 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.455 0.539 . . . . 5.5300000000000002 112.455 -177.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 91.7 m -90.43 -31.43 16.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.933 0.397 . . . . 3.23 111.644 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -115.28 163.5 15.59 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.67 0.271 . . . . 4.79 110.521 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -96.96 121.29 38.68 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.14 -0.482 . . . . 4.71 110.977 -175.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 73.8 mt -65.72 119.87 11.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.244 -0.434 . . . . 6.46 109.903 176.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 101.4 7.81 48.15 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.65 -0.786 . . . . 3.0099999999999998 112.154 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -80.94 147.26 30.36 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.991 0.424 . . . . 2.77 110.178 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 67.0 mt -95.65 110.35 24.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.919 -0.771 . . . . 1.6499999999999999 108.919 172.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 3.4 p -132.42 136.65 28.35 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 116.136 -0.484 . . . . 3.02 110.756 -172.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . 0.55 ' HA ' ' HA ' ' A' ' 345' ' ' MET . 17.7 Cg_endo -58.57 122.05 10.99 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.677 2.251 . . . . 2.96 112.274 177.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.463 ' HA3' ' CG1' ' A' ' 311' ' ' VAL . . . -110.97 -170.33 19.26 Favored Glycine 0 N--CA 1.438 -1.189 0 N-CA-C 111.0 -0.84 . . . . 1.77 111.0 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.445 ' HE3' ' HA2' ' A' ' 341' ' ' GLY . 1.9 tmtm? -152.31 112.48 4.05 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.907 0.384 . . . . 2.3599999999999999 109.979 -175.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 60.3 t -70.74 100.48 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.896 -0.593 . . . . 1.8400000000000001 110.554 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 1.8 t -95.38 -16.15 22.55 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.102 0.477 . . . . 1.24 110.829 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . 0.419 ' HB3' ' HE3' ' A' ' 303' ' ' LYS . 3.1 mmmt -154.98 141.12 18.46 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.848 -0.615 . . . . 1.97 109.997 -178.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.518 ' N ' HD12 ' A' ' 304' ' ' LEU . 0.0 OUTLIER -134.86 140.19 45.62 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.163 -0.615 . . . . 2.1499999999999999 110.791 173.646 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 27.3 m -132.17 162.78 54.67 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.324 -0.853 . . . . 1.47 109.295 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -49.36 -31.32 22.69 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.428 2.085 . . . . 0.84999999999999998 114.166 -173.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -109.75 18.07 20.58 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.949 0.722 . . . . 1.25 112.949 -175.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . 0.558 ' HA2' ' O ' ' A' ' 321' ' ' VAL . . . 162.57 160.35 11.08 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 119.069 -1.539 . . . . 1.1699999999999999 114.342 176.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 320' ' ' LEU . . . -114.45 123.35 49.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.542 0.211 . . . . 1.24 110.484 178.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -76.72 108.91 10.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.43 0.633 . . . . 1.8200000000000001 111.529 -176.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.463 ' CG1' ' HA3' ' A' ' 299' ' ' GLY . 88.5 t -92.73 116.27 33.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 114.986 -1.006 . . . . 1.96 110.871 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' ARG . . . . . 0.437 ' NH2' ' HA ' ' A' ' 315' ' ' GLU . 13.1 tpt180 -75.97 117.19 17.43 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.359 -0.837 . . . . 1.6499999999999999 109.688 175.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 4.8 m -119.04 -35.73 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.866 0.365 . . . . 1.3100000000000001 111.786 -178.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -148.95 155.74 41.27 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.567 -0.531 . . . . 1.8200000000000001 109.567 -176.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' GLU . . . . . 0.437 ' HA ' ' NH2' ' A' ' 312' ' ' ARG . 10.0 tp10 -58.22 113.24 1.84 Allowed 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.536 0.522 . . . . 2.6899999999999999 110.619 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 105.65 -11.3 46.19 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.75 -0.738 . . . . 0.94999999999999996 113.404 177.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 8.1 tt -130.0 124.86 59.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 117.925 0.863 . . . . 1.8400000000000001 113.243 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -126.35 136.93 53.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.689 -1.141 . . . . 1.51 108.662 170.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . 0.522 ' HA3' ' O ' ' A' ' 358' ' ' ILE . . . -130.97 138.64 10.32 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.129 -1.034 . . . . 0.73999999999999999 112.772 -176.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.479 ' HA ' ' O ' ' A' ' 309' ' ' ALA . 0.0 OUTLIER -80.55 144.31 32.55 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.014 0.435 . . . . 2.5899999999999999 111.223 -177.767 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . 0.558 ' O ' ' HA2' ' A' ' 308' ' ' GLY . 29.3 m -98.0 138.6 22.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.469 -0.937 . . . . 1.76 108.469 172.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -59.27 147.73 34.61 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.947 0.403 . . . . 2.6600000000000001 110.981 -173.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.555 HD11 ' O ' ' A' ' 323' ' ' ILE . 0.0 OUTLIER -61.31 -21.48 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 115.845 -0.616 . . . . 2.3500000000000001 110.095 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 5.1 m -69.76 -20.41 63.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.799 -0.637 . . . . 2.3999999999999999 110.555 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' GLU . . . . . 0.681 ' OE1' ' HG2' ' A' ' 363' ' ' LYS . 65.7 mm-40 -69.78 -15.38 63.11 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.898 -0.592 . . . . 2.6200000000000001 110.513 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.419 HD12 HG12 ' A' ' 323' ' ' ILE . 49.2 mt -86.67 33.88 0.65 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.622 -0.717 . . . . 2.5 110.651 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . 74.77 -175.38 0.14 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.125 -0.943 . . . . 2.7799999999999998 110.56 -177.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -94.02 -0.57 55.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.066 0.46 . . . . 3.3100000000000001 110.891 -171.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' ARG . . . . . 0.466 ' CZ ' HG23 ' A' ' 331' ' ' VAL . 11.5 ptt85 -84.2 -179.71 7.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.203 0.525 . . . . 2.4300000000000002 111.198 -177.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -82.51 112.99 19.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.421 -0.809 . . . . 2.9900000000000002 110.35 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' VAL . . . . . 0.519 HG11 HE21 ' A' ' 336' ' ' GLN . 48.1 t -129.02 123.31 58.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.094 0.474 . . . . 1.95 110.894 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -71.45 -36.09 71.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.636 -0.711 . . . . 3.8300000000000001 111.712 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 7.1 p -160.76 139.64 7.66 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.694 -0.684 . . . . 2.5800000000000001 109.34 -175.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -44.46 -23.69 0.86 Allowed 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 124.121 3.214 . . . . 1.76 113.721 177.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' A' ' 338' ' ' VAL . 30.2 t70 -60.67 -21.29 62.66 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 123.64 0.588 . . . . 2.1499999999999999 111.579 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . 0.519 HE21 HG11 ' A' ' 331' ' ' VAL . 10.6 mt-30 -66.48 -32.79 74.38 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.037 0.446 . . . . 2.27 110.62 176.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 52.0 t -103.09 -54.51 6.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.896 -0.593 . . . . 2.6099999999999999 110.673 -173.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 335' ' ' ASP . 33.0 m -116.83 161.76 15.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.896 -0.593 . . . . 2.6699999999999999 110.251 -178.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -124.88 168.4 13.32 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.098 0.475 . . . . 1.9399999999999999 110.482 177.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 8.2 p -57.25 134.35 21.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.207 -0.906 . . . . 2.8100000000000001 109.857 174.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . 0.445 ' HA2' ' HE3' ' A' ' 300' ' ' LYS . . . 100.49 -2.47 56.1 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.491 -0.861 . . . . 2.1800000000000002 112.869 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -70.39 124.62 24.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.817 0.342 . . . . 1.6000000000000001 110.977 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -110.33 113.63 26.44 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.363 -0.606 . . . . 2.0299999999999998 109.363 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -146.58 150.36 35.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.521 0.2 . . . . 2.1400000000000001 111.157 -175.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' MET . . . . . 0.55 ' HA ' ' HA ' ' A' ' 298' ' ' PRO . 18.2 ptm -78.79 120.16 23.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.26 0.552 . . . . 3.46 110.517 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.59 151.7 34.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.705 -0.679 . . . . 2.0 109.641 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 360' ' ' LEU . 1.8 ttmt -88.52 125.73 34.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.609 0.242 . . . . 2.5099999999999998 111.181 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 87.0 t -74.71 101.11 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.824 -0.625 . . . . 2.0899999999999999 109.455 173.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 359' ' ' SER . 6.0 pt -92.53 -20.53 6.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.964 -0.562 . . . . 1.54 111.267 -174.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -161.89 161.77 28.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.921 0.391 . . . . 1.4399999999999999 110.717 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 1.3 mm -137.04 117.18 16.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.338 -0.846 . . . . 2.04 109.335 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' ASP . . . . . 0.484 ' HB3' ' HB2' ' A' ' 355' ' ' ARG . 12.1 m-20 -83.59 96.35 8.62 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.296 0.57 . . . . 3.6499999999999999 109.935 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -57.1 -51.87 67.57 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.423 -1.262 . . . . 3.0 110.83 -176.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -90.89 -14.2 32.16 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.062 0.764 . . . . 3.7999999999999998 113.062 -174.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' ARG . . . . . 0.484 ' HB2' ' HB3' ' A' ' 352' ' ' ASP . 2.2 mpt_? -100.04 -1.13 37.73 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.062 -0.655 . . . . 3.9199999999999999 110.699 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . 0.642 ' HD2' ' N ' ' A' ' 356' ' ' ARG . 2.6 mpt_? 52.89 45.97 27.7 Favored 'General case' 0 C--N 1.335 -0.064 0 CA-C-N 115.008 -0.996 . . . . 3.5099999999999998 111.33 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 30.8 mtp180 -130.51 169.07 16.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.683 -0.689 . . . . 2.8500000000000001 110.103 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.522 ' O ' ' HA3' ' A' ' 319' ' ' GLY . 6.5 tt -140.54 136.65 36.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.719 -0.474 . . . . 2.4500000000000002 109.719 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.477 ' O ' HG12 ' A' ' 349' ' ' ILE . 66.8 m -102.49 130.94 49.45 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.476 -0.329 . . . . 1.04 110.558 -177.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.505 ' HA ' ' O ' ' A' ' 347' ' ' LYS . 3.3 mp -139.65 145.51 38.54 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.344 -0.389 . . . . 1.73 110.369 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 53.9 m -131.88 126.78 35.03 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.308 0.575 . . . . 1.74 111.06 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 52.3 mt -68.78 -27.47 65.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.242 -0.89 . . . . 2.4900000000000002 110.759 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' LYS . . . . . 0.681 ' HG2' ' OE1' ' A' ' 325' ' ' GLU . 0.0 OUTLIER -58.86 -44.98 91.17 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.061 0.457 . . . . 1.6699999999999999 109.865 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . 0.428 ' HB3' ' HD2' ' A' ' 347' ' ' LYS . 33.1 mm-40 -70.83 -31.5 68.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.555 -0.748 . . . . 2.48 111.431 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -70.11 -32.24 70.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.98 0.419 . . . . 1.3300000000000001 110.704 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -75.54 -28.58 59.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.042 -0.527 . . . . 1.7 110.328 175.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -66.0 -34.27 77.7 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.425 -0.807 . . . . 2.8100000000000001 111.178 -176.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.8 t70 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.578 -0.725 . . . . 2.3599999999999999 110.533 -179.809 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 282' ' ' ASP . . . . . 0.642 ' CB ' ' HD2' ' A' ' 283' ' ' PRO . 0.3 OUTLIER . . . . . 0 CA--C 1.551 1.011 0 CA-C-O 117.258 -1.353 . . . . 5.71 108.998 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 283' ' ' PRO . . . . . 0.642 ' HD2' ' CB ' ' A' ' 282' ' ' ASP . 20.5 Cg_exo -12.32 -63.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.377 2.066 1 C-N-CA 126.231 4.621 . . . . 4.3 118.006 -175.753 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 284' ' ' TRP . . . . . . . . . . . . . 17.2 p90 -56.65 -42.04 78.26 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.051 0.453 . . . . 5.85 111.283 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' ARG . . . . . 0.618 HH11 ' HB2' ' A' ' 285' ' ' ARG . 0.0 OUTLIER -65.01 -41.71 95.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.854 -0.612 . . . . 3.91 110.025 172.263 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 286' ' ' HIS . . . . . 0.431 ' HB3' ' O ' ' A' ' 283' ' ' PRO . 14.2 t-80 -56.46 -36.45 69.06 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.858 -1.065 . . . . 2.78 111.06 -173.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -54.16 -48.61 70.69 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.916 -0.401 . . . . 1.2 109.916 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -57.71 -39.1 76.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.593 -0.73 . . . . 1.73 111.636 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 38.3 mtt-85 -88.5 0.76 55.96 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.931 -0.577 . . . . 4.87 112.032 -176.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 61.7 m -122.39 -33.68 3.41 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.113 0.412 . . . . 2.73 112.113 -174.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -117.68 129.74 55.91 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.814 -0.355 . . . . 4.05 110.456 -176.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -75.77 132.23 40.3 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.879 -0.601 . . . . 4.31 110.262 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 65.3 mt -73.89 137.13 23.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.275 -0.42 . . . . 6.07 110.318 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 105.14 -7.98 44.67 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.852 -0.689 . . . . 2.84 112.861 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' GLN . . . . . 0.405 ' HG3' ' CG2' ' A' ' 297' ' ' VAL . 13.0 pt20 -85.85 152.17 23.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.036 0.446 . . . . 2.47 110.728 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.417 HG22 ' HB2' ' A' ' 345' ' ' MET . 2.3 mp -95.26 120.76 45.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.702 -0.681 . . . . 1.1 109.241 178.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.405 ' CG2' ' HG3' ' A' ' 295' ' ' GLN . 17.2 t -130.28 135.09 26.89 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.539 -0.301 . . . . 2.4 111.284 -173.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 298' ' ' PRO . . . . . 0.588 ' HA ' ' HA ' ' A' ' 345' ' ' MET . 24.3 Cg_exo -64.4 123.86 12.45 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.774 2.316 . . . . 2.52 111.791 173.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 343' ' ' ASP . . . -123.58 -175.2 14.4 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 111.095 -0.802 . . . . 1.77 111.095 176.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -127.23 111.83 14.4 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.607 0.242 . . . . 1.82 110.447 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 61.1 t -71.6 100.72 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.448 -0.575 . . . . 1.22 109.448 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 302' ' ' THR . . . . . 0.49 ' O ' HG23 ' A' ' 340' ' ' VAL . 3.4 t -88.07 -44.02 11.26 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.951 -0.568 . . . . 0.73 110.796 -175.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 6.2 ttpp -129.53 160.87 31.87 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-O 120.769 0.318 . . . . 1.58 111.142 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.468 HD13 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -151.48 151.67 31.96 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.173 -0.467 . . . . 1.56 111.289 -179.075 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 1.5 m -150.41 154.89 36.34 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 108.714 -0.847 . . . . 0.88 108.714 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.18 -16.58 3.01 Favored 'Trans proline' 0 N--CA 1.479 0.629 0 C-N-CA 123.795 2.997 . . . . 0.76 115.319 -169.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -106.96 -16.98 14.31 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.554 0.575 . . . . 1.12 112.554 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 308' ' ' GLY . . . . . 0.573 ' HA2' ' O ' ' A' ' 321' ' ' VAL . . . -173.62 160.22 30.34 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.293 -0.956 . . . . 1.17 112.959 -176.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 309' ' ' ALA . . . . . 0.599 ' O ' ' HA ' ' A' ' 320' ' ' LEU . . . -123.39 149.06 45.45 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 117.161 0.48 . . . . 0.72 110.58 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 310' ' ' PHE . . . . . 0.424 ' CZ ' HD12 ' A' ' 320' ' ' LEU . 66.5 m-85 -105.21 117.19 33.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.08 0.467 . . . . 1.4 111.432 -176.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 3.0 p -104.39 134.96 44.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.686 -0.688 . . . . 1.37 110.253 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 312' ' ' ARG . . . . . 0.431 ' HD2' ' HG2' ' A' ' 318' ' ' GLU . 10.2 mmm180 -84.5 110.75 18.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.155 -0.475 . . . . 1.25 110.105 177.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.532 HG21 HD13 ' A' ' 358' ' ' ILE . 3.8 m -105.54 -42.88 7.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.924 0.392 . . . . 0.81 110.919 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -145.63 148.14 32.79 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.182 -1.044 . . . . 1.82 108.182 176.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -56.35 115.37 2.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.043 0.449 . . . . 2.69 111.637 -173.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 105.99 -19.48 37.95 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.65 -0.705 . . . . 0.95 113.166 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.444 HG23 HG23 ' A' ' 313' ' ' VAL . 6.2 tt -117.62 127.65 74.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.655 0.741 . . . . 1.23 111.339 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.431 ' HG2' ' HD2' ' A' ' 312' ' ' ARG . 43.8 mt-10 -123.44 133.17 54.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.248 -0.887 . . . . 1.51 110.363 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 319' ' ' GLY . . . . . 0.642 ' CA ' HG23 ' A' ' 358' ' ' ILE . . . -96.89 124.66 8.19 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.873 -0.68 . . . . 0.74 112.303 -175.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.599 ' HA ' ' O ' ' A' ' 309' ' ' ALA . 10.5 tt -91.09 132.35 36.1 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.572 -0.529 . . . . 2.04 109.572 178.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 321' ' ' VAL . . . . . 0.573 ' O ' ' HA2' ' A' ' 308' ' ' GLY . 29.9 m -118.79 114.34 44.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.623 -0.51 . . . . 1.07 109.623 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -59.75 152.14 23.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.128 0.49 . . . . 2.41 110.502 -174.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 8.9 tp -53.12 -25.87 10.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.013 -0.994 . . . . 1.81 111.94 -177.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 42.4 t -82.89 -25.65 32.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.082 -0.508 . . . . 2.08 111.031 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -78.76 -10.93 59.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.15 0.5 . . . . 2.62 110.018 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 96.0 mt -79.95 -49.34 12.0 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.567 -0.742 . . . . 1.98 110.682 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -154.94 162.21 41.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.153 0.502 . . . . 2.32 111.208 -176.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -84.86 -12.87 52.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.218 -0.901 . . . . 3.31 110.737 -175.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 329' ' ' ARG . . . . . 0.523 ' HG2' ' N ' ' A' ' 330' ' ' HIS . 0.0 OUTLIER -105.19 176.59 5.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.118 -0.492 . . . . 2.17 110.683 -178.781 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 330' ' ' HIS . . . . . 0.523 ' N ' ' HG2' ' A' ' 329' ' ' ARG . 70.9 t60 -60.57 106.7 0.58 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.93 -0.577 . . . . 2.6 111.501 177.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 331' ' ' VAL . . . . . 0.404 HG22 ' CZ ' ' A' ' 329' ' ' ARG . 44.3 t -104.99 121.44 56.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.744 -0.835 . . . . 1.43 108.744 170.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -70.87 -59.25 2.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.538 0.685 . . . . 3.83 109.982 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 8.6 p -133.06 140.98 39.22 Favored Pre-proline 0 C--N 1.319 -0.733 0 N-CA-C 108.033 -1.099 . . . . 2.0 108.033 175.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -43.46 -25.08 0.72 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.925 3.084 . . . . 1.47 114.008 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -53.15 -30.19 35.66 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 123.777 0.673 . . . . 2.15 111.753 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -58.14 -40.14 80.59 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 120.955 0.407 . . . . 2.27 110.884 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 38.9 t -102.86 -45.5 10.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.024 -0.535 . . . . 2.07 110.344 -174.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.77 118.65 34.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.808 -0.633 . . . . 2.23 110.718 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -103.9 169.89 8.24 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.124 -0.489 . . . . 1.49 110.188 176.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 302' ' ' THR . 14.3 p -51.17 123.84 3.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.67 -0.695 . . . . 2.3 111.086 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 97.86 -2.43 60.13 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.619 -0.801 . . . . 1.86 112.917 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -65.74 131.49 46.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.818 0.342 . . . . 1.6 110.619 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 343' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 299' ' ' GLY . 11.9 t70 -107.57 103.6 12.96 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.275 -0.639 . . . . 2.03 109.275 178.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -132.09 140.25 48.78 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.685 0.279 . . . . 1.63 111.64 -173.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 345' ' ' MET . . . . . 0.588 ' HA ' ' HA ' ' A' ' 298' ' ' PRO . 0.2 OUTLIER -82.48 121.65 27.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.283 0.563 . . . . 3.05 110.307 175.182 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.54 153.68 35.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.468 -0.787 . . . . 1.43 109.484 -177.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 347' ' ' LYS . . . . . 0.42 ' HG2' HG23 ' A' ' 349' ' ' ILE . 1.3 ttmt -82.44 122.08 27.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.617 0.246 . . . . 1.98 110.627 178.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 66.8 t -72.83 105.84 2.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.114 -0.698 . . . . 1.57 109.114 172.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 349' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 359' ' ' SER . 9.9 pt -92.52 -24.79 5.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.078 -0.51 . . . . 0.97 111.323 -175.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 350' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -163.21 162.85 25.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.957 0.408 . . . . 1.44 110.938 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -137.06 122.26 25.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.457 -0.792 . . . . 1.45 109.298 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 352' ' ' ASP . . . . . 0.729 ' OD2' ' HD3' ' A' ' 355' ' ' ARG . 12.1 t0 -113.0 73.63 0.82 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.028 -0.73 . . . . 3.65 109.028 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 353' ' ' LEU . . . . . 0.449 HD22 ' C ' ' A' ' 353' ' ' LEU . 0.0 OUTLIER -72.71 -12.93 61.21 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.066 -0.97 . . . . 2.62 111.949 -170.666 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 354' ' ' GLU . . . . . 0.601 ' C ' ' HD2' ' A' ' 355' ' ' ARG . 41.0 mt-10 -87.66 -13.34 42.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.814 0.34 . . . . 3.8 110.808 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 355' ' ' ARG . . . . . 0.729 ' HD3' ' OD2' ' A' ' 352' ' ' ASP . 5.8 mpt_? -116.46 2.5 13.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.672 0.749 . . . . 3.45 109.103 174.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 356' ' ' ARG . . . . . 0.611 HH11 ' HG2' ' A' ' 356' ' ' ARG . 5.5 mmt-85 61.26 43.09 11.2 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 114.19 -1.368 . . . . 3.1 111.09 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 357' ' ' ARG . . . . . 0.441 ' HB2' ' HB3' ' A' ' 352' ' ' ASP . 53.3 mtp180 -125.43 157.52 36.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.779 -0.646 . . . . 2.52 110.423 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.642 HG23 ' CA ' ' A' ' 319' ' ' GLY . 5.0 tt -141.07 143.71 27.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.588 -0.523 . . . . 1.93 109.588 174.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.432 ' O ' HG12 ' A' ' 349' ' ' ILE . 55.9 m -113.75 135.65 53.72 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.425 -0.352 . . . . 0.84 111.164 -174.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.478 ' O ' HG12 ' A' ' 321' ' ' VAL . 4.3 mp -145.13 155.46 43.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.237 -0.438 . . . . 1.15 110.08 178.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 44.3 m -143.09 129.63 20.16 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.962 0.41 . . . . 1.33 110.843 176.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.08 -27.45 66.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.946 -0.57 . . . . 1.96 110.617 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 363' ' ' LYS . . . . . 0.423 ' H ' ' HG2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -60.48 -52.8 63.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.305 0.574 . . . . 1.17 109.837 -179.607 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 364' ' ' GLN . . . . . 0.512 ' HA ' ' HB3' ' A' ' 367' ' ' GLU . 49.1 mt-30 -70.99 -28.09 64.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.229 -0.896 . . . . 1.88 111.47 -178.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -61.07 -41.04 95.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.028 0.442 . . . . 0.81 110.558 175.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -78.16 -29.39 48.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.98 -0.555 . . . . 1.7 110.342 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 367' ' ' GLU . . . . . 0.512 ' HB3' ' HA ' ' A' ' 364' ' ' GLN . 36.5 tt0 -66.99 -44.0 81.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.378 -0.828 . . . . 2.81 111.49 -178.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.715 -0.66 . . . . 2.36 110.954 -178.575 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 282' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 N--CA 1.466 0.336 0 CA-C-O 119.825 -0.131 . . . . 5.71 111.302 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -27.84 -62.73 0.08 OUTLIER 'Trans proline' 0 C--N 1.354 0.83 1 C-N-CA 125.513 4.142 . . . . 4.3 115.615 -175.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 284' ' ' TRP . . . . . . . . . . . . . 14.4 p90 -56.19 -43.88 78.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.124 0.487 . . . . 5.85 112.121 -177.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.43 -27.81 34.52 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.433 0.635 . . . . 3.91 110.072 -178.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -66.74 -46.05 76.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.408 -0.815 . . . . 2.78 110.228 175.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -54.03 -48.61 70.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.088 -0.505 . . . . 1.2 110.632 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -54.63 -41.47 70.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.779 -0.646 . . . . 1.73 112.276 -175.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -91.31 -19.75 22.62 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.455 0.539 . . . . 4.87 112.455 -177.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 91.7 m -90.43 -31.43 16.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.933 0.397 . . . . 2.73 111.644 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -115.28 163.5 15.59 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.67 0.271 . . . . 4.05 110.521 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -96.96 121.29 38.68 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.14 -0.482 . . . . 4.31 110.977 -175.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 73.8 mt -65.72 119.87 11.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.244 -0.434 . . . . 6.07 109.903 176.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 101.4 7.81 48.15 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.65 -0.786 . . . . 2.84 112.154 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -80.94 147.26 30.36 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.991 0.424 . . . . 2.47 110.178 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.416 HG12 ' HB2' ' A' ' 347' ' ' LYS . 67.0 mt -95.65 110.35 24.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.919 -0.771 . . . . 1.1 108.919 172.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 3.4 p -132.42 136.65 28.35 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 116.136 -0.484 . . . . 2.4 110.756 -172.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' PRO . . . . . 0.568 ' HA ' ' HA ' ' A' ' 345' ' ' MET . 17.7 Cg_endo -58.57 122.05 10.99 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.677 2.251 . . . . 2.52 112.274 177.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.474 ' HA3' ' CG1' ' A' ' 311' ' ' VAL . . . -110.97 -170.33 19.26 Favored Glycine 0 N--CA 1.438 -1.189 0 N-CA-C 111.0 -0.84 . . . . 1.77 111.0 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.455 ' HE3' ' HA2' ' A' ' 341' ' ' GLY . 1.9 tmtm? -152.31 112.48 4.05 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.907 0.384 . . . . 1.82 109.979 -175.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 60.3 t -70.74 100.48 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.896 -0.593 . . . . 1.22 110.554 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 1.8 t -95.38 -16.15 22.55 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.102 0.477 . . . . 0.73 110.829 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 303' ' ' LYS . . . . . 0.423 ' HB3' ' HE3' ' A' ' 303' ' ' LYS . 3.1 mmmt -154.98 141.12 18.46 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.848 -0.615 . . . . 1.58 109.997 -178.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.488 HD13 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -134.86 140.19 45.62 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.163 -0.615 . . . . 1.56 110.791 173.646 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 27.3 m -132.17 162.78 54.67 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.324 -0.853 . . . . 0.88 109.295 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -49.36 -31.32 22.69 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.428 2.085 . . . . 0.76 114.166 -173.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -109.75 18.07 20.58 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.949 0.722 . . . . 1.12 112.949 -175.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 308' ' ' GLY . . . . . 0.575 ' HA2' ' O ' ' A' ' 321' ' ' VAL . . . 162.57 160.35 11.08 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 119.069 -1.539 . . . . 1.17 114.342 176.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' ALA . . . . . 0.526 ' HB3' HG22 ' A' ' 321' ' ' VAL . . . -114.45 123.35 49.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.542 0.211 . . . . 0.72 110.484 178.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 310' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -76.72 108.91 10.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.43 0.633 . . . . 1.4 111.529 -176.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.474 ' CG1' ' HA3' ' A' ' 299' ' ' GLY . 88.5 t -92.73 116.27 33.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 114.986 -1.006 . . . . 1.37 110.871 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 312' ' ' ARG . . . . . 0.447 ' NH2' ' HA ' ' A' ' 315' ' ' GLU . 13.1 tpt180 -75.97 117.19 17.43 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.359 -0.837 . . . . 1.25 109.688 175.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.532 HG21 HD13 ' A' ' 358' ' ' ILE . 4.8 m -119.04 -35.73 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.866 0.365 . . . . 0.81 111.786 -178.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -148.95 155.74 41.27 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.567 -0.531 . . . . 1.82 109.567 -176.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 315' ' ' GLU . . . . . 0.447 ' HA ' ' NH2' ' A' ' 312' ' ' ARG . 10.0 tp10 -58.22 113.24 1.84 Allowed 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.536 0.522 . . . . 2.69 110.619 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 105.65 -11.3 46.19 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.75 -0.738 . . . . 0.95 113.404 177.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 8.1 tt -130.0 124.86 59.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 117.925 0.863 . . . . 1.23 113.243 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -126.35 136.93 53.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.689 -1.141 . . . . 1.51 108.662 170.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 319' ' ' GLY . . . . . 0.533 ' HA3' ' O ' ' A' ' 358' ' ' ILE . . . -130.97 138.64 10.32 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.129 -1.034 . . . . 0.74 112.772 -176.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.489 ' HA ' ' O ' ' A' ' 309' ' ' ALA . 0.0 OUTLIER -80.55 144.31 32.55 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.014 0.435 . . . . 2.04 111.223 -177.767 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 321' ' ' VAL . . . . . 0.575 ' O ' ' HA2' ' A' ' 308' ' ' GLY . 29.3 m -98.0 138.6 22.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.469 -0.937 . . . . 1.07 108.469 172.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -59.27 147.73 34.61 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.947 0.403 . . . . 2.41 110.981 -173.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.562 HD13 ' O ' ' A' ' 323' ' ' ILE . 0.0 OUTLIER -61.31 -21.48 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 115.845 -0.616 . . . . 1.81 110.095 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 5.1 m -69.76 -20.41 63.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.799 -0.637 . . . . 2.08 110.555 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 325' ' ' GLU . . . . . 0.686 ' OE1' ' HG2' ' A' ' 363' ' ' LYS . 65.7 mm-40 -69.78 -15.38 63.11 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.898 -0.592 . . . . 2.62 110.513 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.488 HD12 HG12 ' A' ' 323' ' ' ILE . 49.2 mt -86.67 33.88 0.65 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.622 -0.717 . . . . 1.98 110.651 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 327' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 326' ' ' LEU . . . 74.77 -175.38 0.14 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.125 -0.943 . . . . 2.32 110.56 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -94.02 -0.57 55.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.066 0.46 . . . . 3.31 110.891 -171.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 329' ' ' ARG . . . . . 0.465 ' CZ ' HG22 ' A' ' 331' ' ' VAL . 11.5 ptt85 -84.2 -179.71 7.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.203 0.525 . . . . 2.17 111.198 -177.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 330' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -82.51 112.99 19.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.421 -0.809 . . . . 2.6 110.35 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 331' ' ' VAL . . . . . 0.465 HG22 ' CZ ' ' A' ' 329' ' ' ARG . 48.1 t -129.02 123.31 58.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.094 0.474 . . . . 1.43 110.894 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -71.45 -36.09 71.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.636 -0.711 . . . . 3.83 111.712 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.46 HG22 ' H ' ' A' ' 335' ' ' ASP . 7.1 p -160.76 139.64 7.66 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.694 -0.684 . . . . 2.0 109.34 -175.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -44.46 -23.69 0.86 Allowed 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 124.121 3.214 . . . . 1.47 113.721 177.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.46 ' H ' HG22 ' A' ' 333' ' ' VAL . 30.2 t70 -60.67 -21.29 62.66 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 123.64 0.588 . . . . 2.15 111.579 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -66.48 -32.79 74.38 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.037 0.446 . . . . 2.27 110.62 176.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 52.0 t -103.09 -54.51 6.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.896 -0.593 . . . . 2.07 110.673 -173.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 335' ' ' ASP . 33.0 m -116.83 161.76 15.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.896 -0.593 . . . . 2.23 110.251 -178.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -124.88 168.4 13.32 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.098 0.475 . . . . 1.49 110.482 177.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 8.2 p -57.25 134.35 21.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.207 -0.906 . . . . 2.3 109.857 174.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 341' ' ' GLY . . . . . 0.455 ' HA2' ' HE3' ' A' ' 300' ' ' LYS . . . 100.49 -2.47 56.1 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.491 -0.861 . . . . 1.86 112.869 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 342' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' A' ' 300' ' ' LYS . 9.0 t70 -70.39 124.62 24.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.817 0.342 . . . . 1.6 110.977 -179.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -110.33 113.63 26.44 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.363 -0.606 . . . . 2.03 109.363 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -146.58 150.36 35.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.521 0.2 . . . . 1.63 111.157 -175.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 345' ' ' MET . . . . . 0.568 ' HA ' ' HA ' ' A' ' 298' ' ' PRO . 18.2 ptm -78.79 120.16 23.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.26 0.552 . . . . 3.05 110.517 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.59 151.7 34.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.705 -0.679 . . . . 1.43 109.641 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 347' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 360' ' ' LEU . 1.8 ttmt -88.52 125.73 34.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.609 0.242 . . . . 1.98 111.181 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 87.0 t -74.71 101.11 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.824 -0.625 . . . . 1.57 109.455 173.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 349' ' ' ILE . . . . . 0.491 HG12 ' O ' ' A' ' 359' ' ' SER . 6.0 pt -92.53 -20.53 6.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.964 -0.562 . . . . 0.97 111.267 -174.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 350' ' ' ASP . . . . . 0.407 ' HB3' ' HB2' ' A' ' 359' ' ' SER . 2.7 t70 -161.89 161.77 28.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.921 0.391 . . . . 1.44 110.717 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 1.3 mm -137.04 117.18 16.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.338 -0.846 . . . . 1.45 109.335 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 352' ' ' ASP . . . . . 0.51 ' HB3' ' HB2' ' A' ' 355' ' ' ARG . 12.1 m-20 -83.59 96.35 8.62 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.296 0.57 . . . . 3.65 109.935 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 353' ' ' LEU . . . . . 0.423 HD13 ' C ' ' A' ' 353' ' ' LEU . 3.4 tm? -57.1 -51.87 67.57 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.423 -1.262 . . . . 2.62 110.83 -176.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -90.89 -14.2 32.16 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.062 0.764 . . . . 3.8 113.062 -174.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 355' ' ' ARG . . . . . 0.51 ' HB2' ' HB3' ' A' ' 352' ' ' ASP . 2.2 mpt_? -100.04 -1.13 37.73 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.062 -0.655 . . . . 3.45 110.699 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 356' ' ' ARG . . . . . 0.645 ' HD2' ' N ' ' A' ' 356' ' ' ARG . 2.6 mpt_? 52.89 45.97 27.7 Favored 'General case' 0 C--N 1.335 -0.064 0 CA-C-N 115.008 -0.996 . . . . 3.1 111.33 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 30.8 mtp180 -130.51 169.07 16.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.683 -0.689 . . . . 2.52 110.103 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.533 ' O ' ' HA3' ' A' ' 319' ' ' GLY . 6.5 tt -140.54 136.65 36.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.719 -0.474 . . . . 1.93 109.719 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.491 ' O ' HG12 ' A' ' 349' ' ' ILE . 66.8 m -102.49 130.94 49.45 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.476 -0.329 . . . . 0.84 110.558 -177.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.514 ' HA ' ' O ' ' A' ' 347' ' ' LYS . 3.3 mp -139.65 145.51 38.54 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.344 -0.389 . . . . 1.15 110.369 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 53.9 m -131.88 126.78 35.03 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.308 0.575 . . . . 1.33 111.06 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 52.3 mt -68.78 -27.47 65.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.242 -0.89 . . . . 1.96 110.759 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 363' ' ' LYS . . . . . 0.686 ' HG2' ' OE1' ' A' ' 325' ' ' GLU . 0.0 OUTLIER -58.86 -44.98 91.17 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.061 0.457 . . . . 1.17 109.865 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 364' ' ' GLN . . . . . 0.483 ' HB3' ' HD2' ' A' ' 347' ' ' LYS . 33.1 mm-40 -70.83 -31.5 68.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.555 -0.748 . . . . 1.88 111.431 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 365' ' ' ALA . . . . . 0.409 ' HA ' HD13 ' A' ' 296' ' ' ILE . . . -70.11 -32.24 70.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.98 0.419 . . . . 0.81 110.704 178.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -75.54 -28.58 59.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.042 -0.527 . . . . 1.7 110.328 175.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -66.0 -34.27 77.7 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.425 -0.807 . . . . 2.81 111.178 -176.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.8 t70 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.578 -0.725 . . . . 2.36 110.533 -179.809 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 . . . . . 0 N--CA 1.481 1.076 0 N-CA-C 110.049 -0.352 . . . . 8.22 110.049 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 62.18 31.42 17.65 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.681 0.753 . . . . 5.08 109.562 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ASP . . . . . 0.642 ' CB ' ' HD2' ' A' ' 283' ' ' PRO . 0.3 OUTLIER -109.36 -170.62 0.2 Allowed Pre-proline 0 CA--C 1.551 1.011 0 CA-C-O 117.258 -1.353 . . . . 5.71 108.998 -177.314 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 283' ' ' PRO . . . . . 0.642 ' HD2' ' CB ' ' A' ' 282' ' ' ASP . 20.5 Cg_exo -12.32 -63.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.377 2.066 1 C-N-CA 126.231 4.621 . . . . 4.3 118.006 -175.753 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 284' ' ' TRP . . . . . . . . . . . . . 17.2 p90 -56.65 -42.04 78.26 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.051 0.453 . . . . 5.85 111.283 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' ARG . . . . . 0.618 HH11 ' HB2' ' A' ' 285' ' ' ARG . 0.0 OUTLIER -65.01 -41.71 95.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.854 -0.612 . . . . 3.91 110.025 172.263 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 286' ' ' HIS . . . . . 0.431 ' HB3' ' O ' ' A' ' 283' ' ' PRO . 14.2 t-80 -56.46 -36.45 69.06 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.858 -1.065 . . . . 2.78 111.06 -173.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -54.16 -48.61 70.69 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.916 -0.401 . . . . 1.2 109.916 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -57.71 -39.1 76.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.593 -0.73 . . . . 1.73 111.636 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 38.3 mtt-85 -88.5 0.76 55.96 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.931 -0.577 . . . . 4.87 112.032 -176.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 61.7 m -122.39 -33.68 3.41 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.113 0.412 . . . . 2.73 112.113 -174.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -117.68 129.74 55.91 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.814 -0.355 . . . . 4.05 110.456 -176.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -75.77 132.23 40.3 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.879 -0.601 . . . . 4.31 110.262 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 65.3 mt -73.89 137.13 23.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.275 -0.42 . . . . 6.07 110.318 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 105.14 -7.98 44.67 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.852 -0.689 . . . . 2.84 112.861 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' GLN . . . . . 0.405 ' HG3' ' CG2' ' A' ' 297' ' ' VAL . 13.0 pt20 -85.85 152.17 23.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.036 0.446 . . . . 2.47 110.728 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.417 HG22 ' HB2' ' A' ' 345' ' ' MET . 2.3 mp -95.26 120.76 45.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.702 -0.681 . . . . 1.1 109.241 178.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.405 ' CG2' ' HG3' ' A' ' 295' ' ' GLN . 17.2 t -130.28 135.09 26.89 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.539 -0.301 . . . . 2.4 111.284 -173.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 298' ' ' PRO . . . . . 0.588 ' HA ' ' HA ' ' A' ' 345' ' ' MET . 24.3 Cg_exo -64.4 123.86 12.45 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.774 2.316 . . . . 2.52 111.791 173.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 343' ' ' ASP . . . -123.58 -175.2 14.4 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 111.095 -0.802 . . . . 1.77 111.095 176.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -127.23 111.83 14.4 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.607 0.242 . . . . 1.82 110.447 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 61.1 t -71.6 100.72 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.448 -0.575 . . . . 1.22 109.448 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' THR . . . . . 0.49 ' O ' HG23 ' A' ' 340' ' ' VAL . 3.4 t -88.07 -44.02 11.26 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.951 -0.568 . . . . 0.73 110.796 -175.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 6.2 ttpp -129.53 160.87 31.87 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-O 120.769 0.318 . . . . 1.58 111.142 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.468 HD13 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -151.48 151.67 31.96 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.173 -0.467 . . . . 1.56 111.289 -179.075 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 1.5 m -150.41 154.89 36.34 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 108.714 -0.847 . . . . 0.88 108.714 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.18 -16.58 3.01 Favored 'Trans proline' 0 N--CA 1.479 0.629 0 C-N-CA 123.795 2.997 . . . . 0.76 115.319 -169.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -106.96 -16.98 14.31 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.554 0.575 . . . . 1.12 112.554 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' GLY . . . . . 0.573 ' HA2' ' O ' ' A' ' 321' ' ' VAL . . . -173.62 160.22 30.34 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.293 -0.956 . . . . 1.17 112.959 -176.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' ALA . . . . . 0.599 ' O ' ' HA ' ' A' ' 320' ' ' LEU . . . -123.39 149.06 45.45 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 117.161 0.48 . . . . 0.72 110.58 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 310' ' ' PHE . . . . . 0.424 ' CZ ' HD12 ' A' ' 320' ' ' LEU . 66.5 m-85 -105.21 117.19 33.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.08 0.467 . . . . 1.4 111.432 -176.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 3.0 p -104.39 134.96 44.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.686 -0.688 . . . . 1.37 110.253 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' ARG . . . . . 0.431 ' HD2' ' HG2' ' A' ' 318' ' ' GLU . 10.2 mmm180 -84.5 110.75 18.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.155 -0.475 . . . . 1.25 110.105 177.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.532 HG21 HD13 ' A' ' 358' ' ' ILE . 3.8 m -105.54 -42.88 7.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.924 0.392 . . . . 0.81 110.919 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -145.63 148.14 32.79 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.182 -1.044 . . . . 1.82 108.182 176.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -56.35 115.37 2.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.043 0.449 . . . . 2.69 111.637 -173.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 105.99 -19.48 37.95 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.65 -0.705 . . . . 0.95 113.166 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.444 HG23 HG23 ' A' ' 313' ' ' VAL . 6.2 tt -117.62 127.65 74.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.655 0.741 . . . . 1.23 111.339 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.431 ' HG2' ' HD2' ' A' ' 312' ' ' ARG . 43.8 mt-10 -123.44 133.17 54.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.248 -0.887 . . . . 1.51 110.363 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 319' ' ' GLY . . . . . 0.642 ' CA ' HG23 ' A' ' 358' ' ' ILE . . . -96.89 124.66 8.19 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.873 -0.68 . . . . 0.74 112.303 -175.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.599 ' HA ' ' O ' ' A' ' 309' ' ' ALA . 10.5 tt -91.09 132.35 36.1 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.572 -0.529 . . . . 2.04 109.572 178.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.573 ' O ' ' HA2' ' A' ' 308' ' ' GLY . 29.9 m -118.79 114.34 44.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.623 -0.51 . . . . 1.07 109.623 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -59.75 152.14 23.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.128 0.49 . . . . 2.41 110.502 -174.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 8.9 tp -53.12 -25.87 10.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.013 -0.994 . . . . 1.81 111.94 -177.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 42.4 t -82.89 -25.65 32.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.082 -0.508 . . . . 2.08 111.031 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -78.76 -10.93 59.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.15 0.5 . . . . 2.62 110.018 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 96.0 mt -79.95 -49.34 12.0 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.567 -0.742 . . . . 1.98 110.682 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -154.94 162.21 41.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.153 0.502 . . . . 2.32 111.208 -176.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -84.86 -12.87 52.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.218 -0.901 . . . . 3.31 110.737 -175.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' ARG . . . . . 0.523 ' HG2' ' N ' ' A' ' 330' ' ' HIS . 0.0 OUTLIER -105.19 176.59 5.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.118 -0.492 . . . . 2.17 110.683 -178.781 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 330' ' ' HIS . . . . . 0.523 ' N ' ' HG2' ' A' ' 329' ' ' ARG . 70.9 t60 -60.57 106.7 0.58 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.93 -0.577 . . . . 2.6 111.501 177.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' VAL . . . . . 0.404 HG22 ' CZ ' ' A' ' 329' ' ' ARG . 44.3 t -104.99 121.44 56.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.744 -0.835 . . . . 1.43 108.744 170.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -70.87 -59.25 2.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.538 0.685 . . . . 3.83 109.982 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 8.6 p -133.06 140.98 39.22 Favored Pre-proline 0 C--N 1.319 -0.733 0 N-CA-C 108.033 -1.099 . . . . 2.0 108.033 175.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -43.46 -25.08 0.72 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.925 3.084 . . . . 1.47 114.008 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -53.15 -30.19 35.66 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 123.777 0.673 . . . . 2.15 111.753 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -58.14 -40.14 80.59 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 120.955 0.407 . . . . 2.27 110.884 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 38.9 t -102.86 -45.5 10.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.024 -0.535 . . . . 2.07 110.344 -174.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.77 118.65 34.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.808 -0.633 . . . . 2.23 110.718 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -103.9 169.89 8.24 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.124 -0.489 . . . . 1.49 110.188 176.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 302' ' ' THR . 14.3 p -51.17 123.84 3.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.67 -0.695 . . . . 2.3 111.086 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 97.86 -2.43 60.13 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.619 -0.801 . . . . 1.86 112.917 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -65.74 131.49 46.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.818 0.342 . . . . 1.6 110.619 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 343' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 299' ' ' GLY . 11.9 t70 -107.57 103.6 12.96 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.275 -0.639 . . . . 2.03 109.275 178.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -132.09 140.25 48.78 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.685 0.279 . . . . 1.63 111.64 -173.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 345' ' ' MET . . . . . 0.588 ' HA ' ' HA ' ' A' ' 298' ' ' PRO . 0.2 OUTLIER -82.48 121.65 27.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.283 0.563 . . . . 3.05 110.307 175.182 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.54 153.68 35.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.468 -0.787 . . . . 1.43 109.484 -177.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 347' ' ' LYS . . . . . 0.42 ' HG2' HG23 ' A' ' 349' ' ' ILE . 1.3 ttmt -82.44 122.08 27.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.617 0.246 . . . . 1.98 110.627 178.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 66.8 t -72.83 105.84 2.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.114 -0.698 . . . . 1.57 109.114 172.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 349' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 359' ' ' SER . 9.9 pt -92.52 -24.79 5.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.078 -0.51 . . . . 0.97 111.323 -175.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 350' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -163.21 162.85 25.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.957 0.408 . . . . 1.44 110.938 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -137.06 122.26 25.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.457 -0.792 . . . . 1.45 109.298 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 352' ' ' ASP . . . . . 0.729 ' OD2' ' HD3' ' A' ' 355' ' ' ARG . 12.1 t0 -113.0 73.63 0.82 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.028 -0.73 . . . . 3.65 109.028 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 353' ' ' LEU . . . . . 0.449 HD22 ' C ' ' A' ' 353' ' ' LEU . 0.0 OUTLIER -72.71 -12.93 61.21 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.066 -0.97 . . . . 2.62 111.949 -170.666 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 354' ' ' GLU . . . . . 0.601 ' C ' ' HD2' ' A' ' 355' ' ' ARG . 41.0 mt-10 -87.66 -13.34 42.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.814 0.34 . . . . 3.8 110.808 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 355' ' ' ARG . . . . . 0.729 ' HD3' ' OD2' ' A' ' 352' ' ' ASP . 5.8 mpt_? -116.46 2.5 13.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.672 0.749 . . . . 3.45 109.103 174.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 356' ' ' ARG . . . . . 0.611 HH11 ' HG2' ' A' ' 356' ' ' ARG . 5.5 mmt-85 61.26 43.09 11.2 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 114.19 -1.368 . . . . 3.1 111.09 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 357' ' ' ARG . . . . . 0.441 ' HB2' ' HB3' ' A' ' 352' ' ' ASP . 53.3 mtp180 -125.43 157.52 36.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.779 -0.646 . . . . 2.52 110.423 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.642 HG23 ' CA ' ' A' ' 319' ' ' GLY . 5.0 tt -141.07 143.71 27.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.588 -0.523 . . . . 1.93 109.588 174.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.432 ' O ' HG12 ' A' ' 349' ' ' ILE . 55.9 m -113.75 135.65 53.72 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.425 -0.352 . . . . 0.84 111.164 -174.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.478 ' O ' HG12 ' A' ' 321' ' ' VAL . 4.3 mp -145.13 155.46 43.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.237 -0.438 . . . . 1.15 110.08 178.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 44.3 m -143.09 129.63 20.16 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.962 0.41 . . . . 1.33 110.843 176.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.08 -27.45 66.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.946 -0.57 . . . . 1.96 110.617 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 363' ' ' LYS . . . . . 0.423 ' H ' ' HG2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -60.48 -52.8 63.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.305 0.574 . . . . 1.17 109.837 -179.607 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.512 ' HA ' ' HB3' ' A' ' 367' ' ' GLU . 49.1 mt-30 -70.99 -28.09 64.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.229 -0.896 . . . . 1.88 111.47 -178.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -61.07 -41.04 95.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.028 0.442 . . . . 0.81 110.558 175.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -78.16 -29.39 48.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.98 -0.555 . . . . 1.7 110.342 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' GLU . . . . . 0.512 ' HB3' ' HA ' ' A' ' 364' ' ' GLN . 36.5 tt0 -66.99 -44.0 81.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.378 -0.828 . . . . 2.81 111.49 -178.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.715 -0.66 . . . . 2.36 110.954 -178.575 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 121.443 0.639 . . . . 8.22 110.016 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 286' ' ' HIS . 39.2 mt-10 -100.47 84.21 2.74 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.968 -0.56 . . . . 5.08 109.748 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 282' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -63.85 151.19 89.74 Favored Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 115.387 -0.824 . . . . 5.71 111.302 -176.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -27.84 -62.73 0.08 OUTLIER 'Trans proline' 0 C--N 1.354 0.83 1 C-N-CA 125.513 4.142 . . . . 4.3 115.615 -175.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' TRP . . . . . . . . . . . . . 14.4 p90 -56.19 -43.88 78.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.124 0.487 . . . . 5.85 112.121 -177.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' ARG . . . . . 0.432 ' HD2' ' HA ' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -81.43 -27.81 34.52 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.433 0.635 . . . . 3.91 110.072 -178.779 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 286' ' ' HIS . . . . . 0.461 ' HB2' ' O ' ' A' ' 281' ' ' GLU . 74.0 t60 -66.74 -46.05 76.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.408 -0.815 . . . . 2.78 110.228 175.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -54.03 -48.61 70.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.088 -0.505 . . . . 1.2 110.632 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -54.63 -41.47 70.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.779 -0.646 . . . . 1.73 112.276 -175.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -91.31 -19.75 22.62 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.455 0.539 . . . . 4.87 112.455 -177.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 91.7 m -90.43 -31.43 16.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.933 0.397 . . . . 2.73 111.644 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -115.28 163.5 15.59 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.67 0.271 . . . . 4.05 110.521 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -96.96 121.29 38.68 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.14 -0.482 . . . . 4.31 110.977 -175.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 73.8 mt -65.72 119.87 11.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.244 -0.434 . . . . 6.07 109.903 176.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 101.4 7.81 48.15 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.65 -0.786 . . . . 2.84 112.154 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -80.94 147.26 30.36 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.991 0.424 . . . . 2.47 110.178 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.416 HG12 ' HB2' ' A' ' 347' ' ' LYS . 67.0 mt -95.65 110.35 24.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.919 -0.771 . . . . 1.1 108.919 172.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 3.4 p -132.42 136.65 28.35 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 116.136 -0.484 . . . . 2.4 110.756 -172.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' PRO . . . . . 0.568 ' HA ' ' HA ' ' A' ' 345' ' ' MET . 17.7 Cg_endo -58.57 122.05 10.99 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.677 2.251 . . . . 2.52 112.274 177.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.474 ' HA3' ' CG1' ' A' ' 311' ' ' VAL . . . -110.97 -170.33 19.26 Favored Glycine 0 N--CA 1.438 -1.189 0 N-CA-C 111.0 -0.84 . . . . 1.77 111.0 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.455 ' HE3' ' HA2' ' A' ' 341' ' ' GLY . 1.9 tmtm? -152.31 112.48 4.05 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.907 0.384 . . . . 1.82 109.979 -175.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 60.3 t -70.74 100.48 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.896 -0.593 . . . . 1.22 110.554 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 1.8 t -95.38 -16.15 22.55 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.102 0.477 . . . . 0.73 110.829 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' LYS . . . . . 0.423 ' HB3' ' HE3' ' A' ' 303' ' ' LYS . 3.1 mmmt -154.98 141.12 18.46 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.848 -0.615 . . . . 1.58 109.997 -178.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.488 HD13 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -134.86 140.19 45.62 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.163 -0.615 . . . . 1.56 110.791 173.646 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 27.3 m -132.17 162.78 54.67 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.324 -0.853 . . . . 0.88 109.295 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -49.36 -31.32 22.69 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.428 2.085 . . . . 0.76 114.166 -173.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -109.75 18.07 20.58 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.949 0.722 . . . . 1.12 112.949 -175.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' GLY . . . . . 0.575 ' HA2' ' O ' ' A' ' 321' ' ' VAL . . . 162.57 160.35 11.08 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 119.069 -1.539 . . . . 1.17 114.342 176.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' ALA . . . . . 0.526 ' HB3' HG22 ' A' ' 321' ' ' VAL . . . -114.45 123.35 49.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.542 0.211 . . . . 0.72 110.484 178.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 310' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -76.72 108.91 10.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.43 0.633 . . . . 1.4 111.529 -176.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.474 ' CG1' ' HA3' ' A' ' 299' ' ' GLY . 88.5 t -92.73 116.27 33.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 114.986 -1.006 . . . . 1.37 110.871 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 312' ' ' ARG . . . . . 0.447 ' NH2' ' HA ' ' A' ' 315' ' ' GLU . 13.1 tpt180 -75.97 117.19 17.43 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.359 -0.837 . . . . 1.25 109.688 175.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.532 HG21 HD13 ' A' ' 358' ' ' ILE . 4.8 m -119.04 -35.73 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.866 0.365 . . . . 0.81 111.786 -178.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -148.95 155.74 41.27 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.567 -0.531 . . . . 1.82 109.567 -176.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 315' ' ' GLU . . . . . 0.447 ' HA ' ' NH2' ' A' ' 312' ' ' ARG . 10.0 tp10 -58.22 113.24 1.84 Allowed 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.536 0.522 . . . . 2.69 110.619 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 105.65 -11.3 46.19 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.75 -0.738 . . . . 0.95 113.404 177.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 8.1 tt -130.0 124.86 59.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 117.925 0.863 . . . . 1.23 113.243 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -126.35 136.93 53.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.689 -1.141 . . . . 1.51 108.662 170.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' GLY . . . . . 0.533 ' HA3' ' O ' ' A' ' 358' ' ' ILE . . . -130.97 138.64 10.32 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.129 -1.034 . . . . 0.74 112.772 -176.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.489 ' HA ' ' O ' ' A' ' 309' ' ' ALA . 0.0 OUTLIER -80.55 144.31 32.55 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.014 0.435 . . . . 2.04 111.223 -177.767 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.575 ' O ' ' HA2' ' A' ' 308' ' ' GLY . 29.3 m -98.0 138.6 22.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.469 -0.937 . . . . 1.07 108.469 172.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -59.27 147.73 34.61 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.947 0.403 . . . . 2.41 110.981 -173.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.562 HD13 ' O ' ' A' ' 323' ' ' ILE . 0.0 OUTLIER -61.31 -21.48 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 115.845 -0.616 . . . . 1.81 110.095 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 5.1 m -69.76 -20.41 63.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.799 -0.637 . . . . 2.08 110.555 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' GLU . . . . . 0.686 ' OE1' ' HG2' ' A' ' 363' ' ' LYS . 65.7 mm-40 -69.78 -15.38 63.11 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.898 -0.592 . . . . 2.62 110.513 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.488 HD12 HG12 ' A' ' 323' ' ' ILE . 49.2 mt -86.67 33.88 0.65 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.622 -0.717 . . . . 1.98 110.651 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 327' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 326' ' ' LEU . . . 74.77 -175.38 0.14 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.125 -0.943 . . . . 2.32 110.56 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -94.02 -0.57 55.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.066 0.46 . . . . 3.31 110.891 -171.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 329' ' ' ARG . . . . . 0.465 ' CZ ' HG22 ' A' ' 331' ' ' VAL . 11.5 ptt85 -84.2 -179.71 7.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.203 0.525 . . . . 2.17 111.198 -177.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 330' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -82.51 112.99 19.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.421 -0.809 . . . . 2.6 110.35 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' VAL . . . . . 0.465 HG22 ' CZ ' ' A' ' 329' ' ' ARG . 48.1 t -129.02 123.31 58.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.094 0.474 . . . . 1.43 110.894 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -71.45 -36.09 71.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.636 -0.711 . . . . 3.83 111.712 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.46 HG22 ' H ' ' A' ' 335' ' ' ASP . 7.1 p -160.76 139.64 7.66 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.694 -0.684 . . . . 2.0 109.34 -175.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -44.46 -23.69 0.86 Allowed 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 124.121 3.214 . . . . 1.47 113.721 177.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.46 ' H ' HG22 ' A' ' 333' ' ' VAL . 30.2 t70 -60.67 -21.29 62.66 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 123.64 0.588 . . . . 2.15 111.579 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -66.48 -32.79 74.38 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.037 0.446 . . . . 2.27 110.62 176.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 52.0 t -103.09 -54.51 6.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.896 -0.593 . . . . 2.07 110.673 -173.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 335' ' ' ASP . 33.0 m -116.83 161.76 15.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.896 -0.593 . . . . 2.23 110.251 -178.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -124.88 168.4 13.32 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.098 0.475 . . . . 1.49 110.482 177.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 8.2 p -57.25 134.35 21.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.207 -0.906 . . . . 2.3 109.857 174.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' GLY . . . . . 0.455 ' HA2' ' HE3' ' A' ' 300' ' ' LYS . . . 100.49 -2.47 56.1 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.491 -0.861 . . . . 1.86 112.869 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 342' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' A' ' 300' ' ' LYS . 9.0 t70 -70.39 124.62 24.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.817 0.342 . . . . 1.6 110.977 -179.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -110.33 113.63 26.44 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.363 -0.606 . . . . 2.03 109.363 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -146.58 150.36 35.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.521 0.2 . . . . 1.63 111.157 -175.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 345' ' ' MET . . . . . 0.568 ' HA ' ' HA ' ' A' ' 298' ' ' PRO . 18.2 ptm -78.79 120.16 23.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.26 0.552 . . . . 3.05 110.517 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.59 151.7 34.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.705 -0.679 . . . . 1.43 109.641 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 347' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 360' ' ' LEU . 1.8 ttmt -88.52 125.73 34.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.609 0.242 . . . . 1.98 111.181 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 87.0 t -74.71 101.11 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.824 -0.625 . . . . 1.57 109.455 173.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 349' ' ' ILE . . . . . 0.491 HG12 ' O ' ' A' ' 359' ' ' SER . 6.0 pt -92.53 -20.53 6.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.964 -0.562 . . . . 0.97 111.267 -174.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 350' ' ' ASP . . . . . 0.407 ' HB3' ' HB2' ' A' ' 359' ' ' SER . 2.7 t70 -161.89 161.77 28.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.921 0.391 . . . . 1.44 110.717 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 1.3 mm -137.04 117.18 16.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.338 -0.846 . . . . 1.45 109.335 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 352' ' ' ASP . . . . . 0.51 ' HB3' ' HB2' ' A' ' 355' ' ' ARG . 12.1 m-20 -83.59 96.35 8.62 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.296 0.57 . . . . 3.65 109.935 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 353' ' ' LEU . . . . . 0.423 HD13 ' C ' ' A' ' 353' ' ' LEU . 3.4 tm? -57.1 -51.87 67.57 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.423 -1.262 . . . . 2.62 110.83 -176.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -90.89 -14.2 32.16 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.062 0.764 . . . . 3.8 113.062 -174.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 355' ' ' ARG . . . . . 0.51 ' HB2' ' HB3' ' A' ' 352' ' ' ASP . 2.2 mpt_? -100.04 -1.13 37.73 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.062 -0.655 . . . . 3.45 110.699 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 356' ' ' ARG . . . . . 0.645 ' HD2' ' N ' ' A' ' 356' ' ' ARG . 2.6 mpt_? 52.89 45.97 27.7 Favored 'General case' 0 C--N 1.335 -0.064 0 CA-C-N 115.008 -0.996 . . . . 3.1 111.33 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 30.8 mtp180 -130.51 169.07 16.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.683 -0.689 . . . . 2.52 110.103 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.533 ' O ' ' HA3' ' A' ' 319' ' ' GLY . 6.5 tt -140.54 136.65 36.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.719 -0.474 . . . . 1.93 109.719 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.491 ' O ' HG12 ' A' ' 349' ' ' ILE . 66.8 m -102.49 130.94 49.45 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.476 -0.329 . . . . 0.84 110.558 -177.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.514 ' HA ' ' O ' ' A' ' 347' ' ' LYS . 3.3 mp -139.65 145.51 38.54 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.344 -0.389 . . . . 1.15 110.369 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 53.9 m -131.88 126.78 35.03 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.308 0.575 . . . . 1.33 111.06 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 52.3 mt -68.78 -27.47 65.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.242 -0.89 . . . . 1.96 110.759 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 363' ' ' LYS . . . . . 0.686 ' HG2' ' OE1' ' A' ' 325' ' ' GLU . 0.0 OUTLIER -58.86 -44.98 91.17 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.061 0.457 . . . . 1.17 109.865 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.483 ' HB3' ' HD2' ' A' ' 347' ' ' LYS . 33.1 mm-40 -70.83 -31.5 68.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.555 -0.748 . . . . 1.88 111.431 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 365' ' ' ALA . . . . . 0.409 ' HA ' HD13 ' A' ' 296' ' ' ILE . . . -70.11 -32.24 70.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.98 0.419 . . . . 0.81 110.704 178.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -75.54 -28.58 59.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.042 -0.527 . . . . 1.7 110.328 175.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -66.0 -34.27 77.7 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.425 -0.807 . . . . 2.81 111.178 -176.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.8 t70 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.578 -0.725 . . . . 2.36 110.533 -179.809 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' ASP . . . . . 0.642 ' CB ' ' HD2' ' A' ' 283' ' ' PRO . 0.3 OUTLIER . . . . . 0 CA--C 1.551 1.011 0 CA-C-O 117.258 -1.353 . . . . 5.71 108.998 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . 0.642 ' HD2' ' CB ' ' A' ' 282' ' ' ASP . 20.5 Cg_exo -12.32 -63.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.377 2.066 1 C-N-CA 126.231 4.621 . . . . 4.3 118.006 -175.753 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' TRP . . . . . . . . . . . . . 17.2 p90 -56.65 -42.04 78.26 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.051 0.453 . . . . 5.85 111.283 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . 0.618 HH11 ' HB2' ' A' ' 285' ' ' ARG . 0.0 OUTLIER -65.01 -41.71 95.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.854 -0.612 . . . . 3.91 110.025 172.263 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' HIS . . . . . 0.431 ' HB3' ' O ' ' A' ' 283' ' ' PRO . 14.2 t-80 -56.46 -36.45 69.06 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.858 -1.065 . . . . 2.78 111.06 -173.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -54.16 -48.61 70.69 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.916 -0.401 . . . . 1.2 109.916 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -57.71 -39.1 76.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.593 -0.73 . . . . 1.73 111.636 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 38.3 mtt-85 -88.5 0.76 55.96 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.931 -0.577 . . . . 4.87 112.032 -176.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 61.7 m -122.39 -33.68 3.41 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.113 0.412 . . . . 2.73 112.113 -174.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -117.68 129.74 55.91 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.814 -0.355 . . . . 4.05 110.456 -176.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -75.77 132.23 40.3 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.879 -0.601 . . . . 4.31 110.262 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 65.3 mt -73.89 137.13 23.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.275 -0.42 . . . . 6.07 110.318 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 105.14 -7.98 44.67 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.852 -0.689 . . . . 2.84 112.861 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' GLN . . . . . 0.405 ' HG3' ' CG2' ' A' ' 297' ' ' VAL . 13.0 pt20 -85.85 152.17 23.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.036 0.446 . . . . 2.47 110.728 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.417 HG22 ' HB2' ' A' ' 345' ' ' MET . 2.3 mp -95.26 120.76 45.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.702 -0.681 . . . . 1.1 109.241 178.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.405 ' CG2' ' HG3' ' A' ' 295' ' ' GLN . 17.2 t -130.28 135.09 26.89 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.539 -0.301 . . . . 2.4 111.284 -173.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . 0.588 ' HA ' ' HA ' ' A' ' 345' ' ' MET . 24.3 Cg_exo -64.4 123.86 12.45 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.774 2.316 . . . . 2.52 111.791 173.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 343' ' ' ASP . . . -123.58 -175.2 14.4 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 111.095 -0.802 . . . . 1.77 111.095 176.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -127.23 111.83 14.4 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.607 0.242 . . . . 1.82 110.447 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 61.1 t -71.6 100.72 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.448 -0.575 . . . . 1.22 109.448 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . 0.49 ' O ' HG23 ' A' ' 340' ' ' VAL . 3.4 t -88.07 -44.02 11.26 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.951 -0.568 . . . . 0.73 110.796 -175.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 6.2 ttpp -129.53 160.87 31.87 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-O 120.769 0.318 . . . . 1.58 111.142 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.468 HD13 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -151.48 151.67 31.96 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.173 -0.467 . . . . 1.56 111.289 -179.075 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 1.5 m -150.41 154.89 36.34 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 108.714 -0.847 . . . . 0.88 108.714 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.18 -16.58 3.01 Favored 'Trans proline' 0 N--CA 1.479 0.629 0 C-N-CA 123.795 2.997 . . . . 0.76 115.319 -169.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -106.96 -16.98 14.31 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.554 0.575 . . . . 1.12 112.554 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . 0.573 ' HA2' ' O ' ' A' ' 321' ' ' VAL . . . -173.62 160.22 30.34 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.293 -0.956 . . . . 1.17 112.959 -176.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' ALA . . . . . 0.599 ' O ' ' HA ' ' A' ' 320' ' ' LEU . . . -123.39 149.06 45.45 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 117.161 0.48 . . . . 0.72 110.58 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' PHE . . . . . 0.424 ' CZ ' HD12 ' A' ' 320' ' ' LEU . 66.5 m-85 -105.21 117.19 33.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.08 0.467 . . . . 1.4 111.432 -176.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 3.0 p -104.39 134.96 44.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.686 -0.688 . . . . 1.37 110.253 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' ARG . . . . . 0.431 ' HD2' ' HG2' ' A' ' 318' ' ' GLU . 10.2 mmm180 -84.5 110.75 18.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.155 -0.475 . . . . 1.25 110.105 177.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.532 HG21 HD13 ' A' ' 358' ' ' ILE . 3.8 m -105.54 -42.88 7.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.924 0.392 . . . . 0.81 110.919 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -145.63 148.14 32.79 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.182 -1.044 . . . . 1.82 108.182 176.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -56.35 115.37 2.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.043 0.449 . . . . 2.69 111.637 -173.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 105.99 -19.48 37.95 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.65 -0.705 . . . . 0.95 113.166 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.444 HG23 HG23 ' A' ' 313' ' ' VAL . 6.2 tt -117.62 127.65 74.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.655 0.741 . . . . 1.23 111.339 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.431 ' HG2' ' HD2' ' A' ' 312' ' ' ARG . 43.8 mt-10 -123.44 133.17 54.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.248 -0.887 . . . . 1.51 110.363 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . 0.642 ' CA ' HG23 ' A' ' 358' ' ' ILE . . . -96.89 124.66 8.19 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.873 -0.68 . . . . 0.74 112.303 -175.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.599 ' HA ' ' O ' ' A' ' 309' ' ' ALA . 10.5 tt -91.09 132.35 36.1 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.572 -0.529 . . . . 2.04 109.572 178.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . 0.573 ' O ' ' HA2' ' A' ' 308' ' ' GLY . 29.9 m -118.79 114.34 44.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.623 -0.51 . . . . 1.07 109.623 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -59.75 152.14 23.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.128 0.49 . . . . 2.41 110.502 -174.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 8.9 tp -53.12 -25.87 10.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.013 -0.994 . . . . 1.81 111.94 -177.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 42.4 t -82.89 -25.65 32.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.082 -0.508 . . . . 2.08 111.031 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -78.76 -10.93 59.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.15 0.5 . . . . 2.62 110.018 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 96.0 mt -79.95 -49.34 12.0 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.567 -0.742 . . . . 1.98 110.682 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -154.94 162.21 41.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.153 0.502 . . . . 2.32 111.208 -176.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -84.86 -12.87 52.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.218 -0.901 . . . . 3.31 110.737 -175.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' ARG . . . . . 0.523 ' HG2' ' N ' ' A' ' 330' ' ' HIS . 0.0 OUTLIER -105.19 176.59 5.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.118 -0.492 . . . . 2.17 110.683 -178.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' HIS . . . . . 0.523 ' N ' ' HG2' ' A' ' 329' ' ' ARG . 70.9 t60 -60.57 106.7 0.58 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.93 -0.577 . . . . 2.6 111.501 177.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' VAL . . . . . 0.404 HG22 ' CZ ' ' A' ' 329' ' ' ARG . 44.3 t -104.99 121.44 56.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.744 -0.835 . . . . 1.43 108.744 170.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -70.87 -59.25 2.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.538 0.685 . . . . 3.83 109.982 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 8.6 p -133.06 140.98 39.22 Favored Pre-proline 0 C--N 1.319 -0.733 0 N-CA-C 108.033 -1.099 . . . . 2.0 108.033 175.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -43.46 -25.08 0.72 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.925 3.084 . . . . 1.47 114.008 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -53.15 -30.19 35.66 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 123.777 0.673 . . . . 2.15 111.753 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -58.14 -40.14 80.59 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 120.955 0.407 . . . . 2.27 110.884 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 38.9 t -102.86 -45.5 10.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.024 -0.535 . . . . 2.07 110.344 -174.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.77 118.65 34.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.808 -0.633 . . . . 2.23 110.718 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -103.9 169.89 8.24 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.124 -0.489 . . . . 1.49 110.188 176.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 302' ' ' THR . 14.3 p -51.17 123.84 3.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.67 -0.695 . . . . 2.3 111.086 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 97.86 -2.43 60.13 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.619 -0.801 . . . . 1.86 112.917 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -65.74 131.49 46.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.818 0.342 . . . . 1.6 110.619 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 299' ' ' GLY . 11.9 t70 -107.57 103.6 12.96 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.275 -0.639 . . . . 2.03 109.275 178.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -132.09 140.25 48.78 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.685 0.279 . . . . 1.63 111.64 -173.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' MET . . . . . 0.588 ' HA ' ' HA ' ' A' ' 298' ' ' PRO . 0.2 OUTLIER -82.48 121.65 27.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.283 0.563 . . . . 3.05 110.307 175.182 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.54 153.68 35.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.468 -0.787 . . . . 1.43 109.484 -177.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . 0.42 ' HG2' HG23 ' A' ' 349' ' ' ILE . 1.3 ttmt -82.44 122.08 27.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.617 0.246 . . . . 1.98 110.627 178.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 66.8 t -72.83 105.84 2.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.114 -0.698 . . . . 1.57 109.114 172.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 359' ' ' SER . 9.9 pt -92.52 -24.79 5.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.078 -0.51 . . . . 0.97 111.323 -175.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -163.21 162.85 25.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.957 0.408 . . . . 1.44 110.938 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -137.06 122.26 25.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.457 -0.792 . . . . 1.45 109.298 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' ASP . . . . . 0.729 ' OD2' ' HD3' ' A' ' 355' ' ' ARG . 12.1 t0 -113.0 73.63 0.82 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.028 -0.73 . . . . 3.65 109.028 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . 0.449 HD22 ' C ' ' A' ' 353' ' ' LEU . 0.0 OUTLIER -72.71 -12.93 61.21 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.066 -0.97 . . . . 2.62 111.949 -170.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' GLU . . . . . 0.601 ' C ' ' HD2' ' A' ' 355' ' ' ARG . 41.0 mt-10 -87.66 -13.34 42.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.814 0.34 . . . . 3.8 110.808 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' ARG . . . . . 0.729 ' HD3' ' OD2' ' A' ' 352' ' ' ASP . 5.8 mpt_? -116.46 2.5 13.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.672 0.749 . . . . 3.45 109.103 174.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . 0.611 HH11 ' HG2' ' A' ' 356' ' ' ARG . 5.5 mmt-85 61.26 43.09 11.2 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 114.19 -1.368 . . . . 3.1 111.09 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' ARG . . . . . 0.441 ' HB2' ' HB3' ' A' ' 352' ' ' ASP . 53.3 mtp180 -125.43 157.52 36.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.779 -0.646 . . . . 2.52 110.423 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.642 HG23 ' CA ' ' A' ' 319' ' ' GLY . 5.0 tt -141.07 143.71 27.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.588 -0.523 . . . . 1.93 109.588 174.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.432 ' O ' HG12 ' A' ' 349' ' ' ILE . 55.9 m -113.75 135.65 53.72 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.425 -0.352 . . . . 0.84 111.164 -174.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.478 ' O ' HG12 ' A' ' 321' ' ' VAL . 4.3 mp -145.13 155.46 43.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.237 -0.438 . . . . 1.15 110.08 178.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 44.3 m -143.09 129.63 20.16 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.962 0.41 . . . . 1.33 110.843 176.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.08 -27.45 66.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.946 -0.57 . . . . 1.96 110.617 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' LYS . . . . . 0.423 ' H ' ' HG2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -60.48 -52.8 63.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.305 0.574 . . . . 1.17 109.837 -179.607 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' GLN . . . . . 0.512 ' HA ' ' HB3' ' A' ' 367' ' ' GLU . 47.7 mt-30 -70.99 -28.09 64.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.229 -0.896 . . . . 1.88 111.47 -178.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -61.07 -41.04 95.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.028 0.442 . . . . 0.81 110.558 175.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -78.16 -29.39 48.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.98 -0.555 . . . . 1.7 110.342 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . 0.512 ' HB3' ' HA ' ' A' ' 364' ' ' GLN . 36.5 tt0 -66.99 -44.0 81.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.378 -0.828 . . . . 2.81 111.49 -178.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.715 -0.66 . . . . 2.36 110.954 -178.575 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 N--CA 1.466 0.336 0 CA-C-O 119.825 -0.131 . . . . 5.71 111.302 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -27.84 -62.73 0.08 OUTLIER 'Trans proline' 0 C--N 1.354 0.83 1 C-N-CA 125.513 4.142 . . . . 4.3 115.615 -175.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' TRP . . . . . . . . . . . . . 14.4 p90 -56.19 -43.88 78.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.124 0.487 . . . . 5.85 112.121 -177.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.43 -27.81 34.52 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.433 0.635 . . . . 3.91 110.072 -178.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -66.74 -46.05 76.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.408 -0.815 . . . . 2.78 110.228 175.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -54.03 -48.61 70.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.088 -0.505 . . . . 1.2 110.632 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -54.63 -41.47 70.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.779 -0.646 . . . . 1.73 112.276 -175.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -91.31 -19.75 22.62 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.455 0.539 . . . . 4.87 112.455 -177.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 91.7 m -90.43 -31.43 16.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.933 0.397 . . . . 2.73 111.644 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -115.28 163.5 15.59 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.67 0.271 . . . . 4.05 110.521 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -96.96 121.29 38.68 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.14 -0.482 . . . . 4.31 110.977 -175.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 73.8 mt -65.72 119.87 11.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.244 -0.434 . . . . 6.07 109.903 176.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 101.4 7.81 48.15 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.65 -0.786 . . . . 2.84 112.154 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -80.94 147.26 30.36 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.991 0.424 . . . . 2.47 110.178 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.416 HG12 ' HB2' ' A' ' 347' ' ' LYS . 67.0 mt -95.65 110.35 24.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.919 -0.771 . . . . 1.1 108.919 172.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 3.4 p -132.42 136.65 28.35 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 116.136 -0.484 . . . . 2.4 110.756 -172.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . 0.568 ' HA ' ' HA ' ' A' ' 345' ' ' MET . 17.7 Cg_endo -58.57 122.05 10.99 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.677 2.251 . . . . 2.52 112.274 177.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.474 ' HA3' ' CG1' ' A' ' 311' ' ' VAL . . . -110.97 -170.33 19.26 Favored Glycine 0 N--CA 1.438 -1.189 0 N-CA-C 111.0 -0.84 . . . . 1.77 111.0 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.455 ' HE3' ' HA2' ' A' ' 341' ' ' GLY . 1.9 tmtm? -152.31 112.48 4.05 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.907 0.384 . . . . 1.82 109.979 -175.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 60.3 t -70.74 100.48 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.896 -0.593 . . . . 1.22 110.554 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 1.8 t -95.38 -16.15 22.55 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.102 0.477 . . . . 0.73 110.829 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' LYS . . . . . 0.423 ' HB3' ' HE3' ' A' ' 303' ' ' LYS . 3.1 mmmt -154.98 141.12 18.46 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.848 -0.615 . . . . 1.58 109.997 -178.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.488 HD13 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -134.86 140.19 45.62 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.163 -0.615 . . . . 1.56 110.791 173.646 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 27.3 m -132.17 162.78 54.67 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.324 -0.853 . . . . 0.88 109.295 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -49.36 -31.32 22.69 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.428 2.085 . . . . 0.76 114.166 -173.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -109.75 18.07 20.58 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.949 0.722 . . . . 1.12 112.949 -175.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . 0.575 ' HA2' ' O ' ' A' ' 321' ' ' VAL . . . 162.57 160.35 11.08 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 119.069 -1.539 . . . . 1.17 114.342 176.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' ALA . . . . . 0.526 ' HB3' HG22 ' A' ' 321' ' ' VAL . . . -114.45 123.35 49.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.542 0.211 . . . . 0.72 110.484 178.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -76.72 108.91 10.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.43 0.633 . . . . 1.4 111.529 -176.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.474 ' CG1' ' HA3' ' A' ' 299' ' ' GLY . 88.5 t -92.73 116.27 33.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 114.986 -1.006 . . . . 1.37 110.871 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' ARG . . . . . 0.447 ' NH2' ' HA ' ' A' ' 315' ' ' GLU . 13.1 tpt180 -75.97 117.19 17.43 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.359 -0.837 . . . . 1.25 109.688 175.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.532 HG21 HD13 ' A' ' 358' ' ' ILE . 4.8 m -119.04 -35.73 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.866 0.365 . . . . 0.81 111.786 -178.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -148.95 155.74 41.27 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.567 -0.531 . . . . 1.82 109.567 -176.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' GLU . . . . . 0.447 ' HA ' ' NH2' ' A' ' 312' ' ' ARG . 10.0 tp10 -58.22 113.24 1.84 Allowed 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.536 0.522 . . . . 2.69 110.619 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 105.65 -11.3 46.19 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.75 -0.738 . . . . 0.95 113.404 177.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 8.1 tt -130.0 124.86 59.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 117.925 0.863 . . . . 1.23 113.243 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -126.35 136.93 53.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.689 -1.141 . . . . 1.51 108.662 170.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . 0.533 ' HA3' ' O ' ' A' ' 358' ' ' ILE . . . -130.97 138.64 10.32 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.129 -1.034 . . . . 0.74 112.772 -176.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.489 ' HA ' ' O ' ' A' ' 309' ' ' ALA . 0.0 OUTLIER -80.55 144.31 32.55 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.014 0.435 . . . . 2.04 111.223 -177.767 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . 0.575 ' O ' ' HA2' ' A' ' 308' ' ' GLY . 29.3 m -98.0 138.6 22.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.469 -0.937 . . . . 1.07 108.469 172.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -59.27 147.73 34.61 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.947 0.403 . . . . 2.41 110.981 -173.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.562 HD13 ' O ' ' A' ' 323' ' ' ILE . 0.0 OUTLIER -61.31 -21.48 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 115.845 -0.616 . . . . 1.81 110.095 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 5.1 m -69.76 -20.41 63.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.799 -0.637 . . . . 2.08 110.555 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' GLU . . . . . 0.686 ' OE1' ' HG2' ' A' ' 363' ' ' LYS . 65.7 mm-40 -69.78 -15.38 63.11 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.898 -0.592 . . . . 2.62 110.513 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.488 HD12 HG12 ' A' ' 323' ' ' ILE . 49.2 mt -86.67 33.88 0.65 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.622 -0.717 . . . . 1.98 110.651 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 326' ' ' LEU . . . 74.77 -175.38 0.14 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.125 -0.943 . . . . 2.32 110.56 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -94.02 -0.57 55.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.066 0.46 . . . . 3.31 110.891 -171.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' ARG . . . . . 0.465 ' CZ ' HG22 ' A' ' 331' ' ' VAL . 11.5 ptt85 -84.2 -179.71 7.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.203 0.525 . . . . 2.17 111.198 -177.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -82.51 112.99 19.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.421 -0.809 . . . . 2.6 110.35 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' VAL . . . . . 0.532 HG13 HE21 ' A' ' 336' ' ' GLN . 48.1 t -129.02 123.31 58.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.094 0.474 . . . . 1.43 110.894 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -71.45 -36.09 71.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.636 -0.711 . . . . 3.83 111.712 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.46 HG22 ' H ' ' A' ' 335' ' ' ASP . 7.1 p -160.76 139.64 7.66 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.694 -0.684 . . . . 2.0 109.34 -175.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -44.46 -23.69 0.86 Allowed 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 124.121 3.214 . . . . 1.47 113.721 177.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.46 ' H ' HG22 ' A' ' 333' ' ' VAL . 30.2 t70 -60.67 -21.29 62.66 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 123.64 0.588 . . . . 2.15 111.579 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' GLN . . . . . 0.532 HE21 HG13 ' A' ' 331' ' ' VAL . 10.6 mt-30 -66.48 -32.79 74.38 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.037 0.446 . . . . 2.27 110.62 176.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 52.0 t -103.09 -54.51 6.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.896 -0.593 . . . . 2.07 110.673 -173.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 335' ' ' ASP . 33.0 m -116.83 161.76 15.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.896 -0.593 . . . . 2.23 110.251 -178.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -124.88 168.4 13.32 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.098 0.475 . . . . 1.49 110.482 177.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 8.2 p -57.25 134.35 21.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.207 -0.906 . . . . 2.3 109.857 174.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' GLY . . . . . 0.455 ' HA2' ' HE3' ' A' ' 300' ' ' LYS . . . 100.49 -2.47 56.1 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.491 -0.861 . . . . 1.86 112.869 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' A' ' 300' ' ' LYS . 9.0 t70 -70.39 124.62 24.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.817 0.342 . . . . 1.6 110.977 -179.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -110.33 113.63 26.44 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.363 -0.606 . . . . 2.03 109.363 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -146.58 150.36 35.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.521 0.2 . . . . 1.63 111.157 -175.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' MET . . . . . 0.568 ' HA ' ' HA ' ' A' ' 298' ' ' PRO . 18.2 ptm -78.79 120.16 23.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.26 0.552 . . . . 3.05 110.517 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.59 151.7 34.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.705 -0.679 . . . . 1.43 109.641 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 360' ' ' LEU . 1.8 ttmt -88.52 125.73 34.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.609 0.242 . . . . 1.98 111.181 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 87.0 t -74.71 101.11 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.824 -0.625 . . . . 1.57 109.455 173.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' ILE . . . . . 0.491 HG12 ' O ' ' A' ' 359' ' ' SER . 6.0 pt -92.53 -20.53 6.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.964 -0.562 . . . . 0.97 111.267 -174.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' ASP . . . . . 0.407 ' HB3' ' HB2' ' A' ' 359' ' ' SER . 2.7 t70 -161.89 161.77 28.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.921 0.391 . . . . 1.44 110.717 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 1.3 mm -137.04 117.18 16.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.338 -0.846 . . . . 1.45 109.335 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' ASP . . . . . 0.51 ' HB3' ' HB2' ' A' ' 355' ' ' ARG . 12.1 m-20 -83.59 96.35 8.62 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.296 0.57 . . . . 3.65 109.935 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . 0.423 HD13 ' C ' ' A' ' 353' ' ' LEU . 3.4 tm? -57.1 -51.87 67.57 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.423 -1.262 . . . . 2.62 110.83 -176.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -90.89 -14.2 32.16 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.062 0.764 . . . . 3.8 113.062 -174.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' ARG . . . . . 0.51 ' HB2' ' HB3' ' A' ' 352' ' ' ASP . 2.2 mpt_? -100.04 -1.13 37.73 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.062 -0.655 . . . . 3.45 110.699 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . 0.645 ' HD2' ' N ' ' A' ' 356' ' ' ARG . 2.6 mpt_? 52.89 45.97 27.7 Favored 'General case' 0 C--N 1.335 -0.064 0 CA-C-N 115.008 -0.996 . . . . 3.1 111.33 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 30.8 mtp180 -130.51 169.07 16.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.683 -0.689 . . . . 2.52 110.103 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.533 ' O ' ' HA3' ' A' ' 319' ' ' GLY . 6.5 tt -140.54 136.65 36.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.719 -0.474 . . . . 1.93 109.719 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.491 ' O ' HG12 ' A' ' 349' ' ' ILE . 66.8 m -102.49 130.94 49.45 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.476 -0.329 . . . . 0.84 110.558 -177.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.514 ' HA ' ' O ' ' A' ' 347' ' ' LYS . 3.3 mp -139.65 145.51 38.54 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.344 -0.389 . . . . 1.15 110.369 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 53.9 m -131.88 126.78 35.03 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.308 0.575 . . . . 1.33 111.06 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 52.3 mt -68.78 -27.47 65.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.242 -0.89 . . . . 1.96 110.759 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' LYS . . . . . 0.686 ' HG2' ' OE1' ' A' ' 325' ' ' GLU . 0.0 OUTLIER -58.86 -44.98 91.17 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.061 0.457 . . . . 1.17 109.865 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' GLN . . . . . 0.483 ' HB3' ' HD2' ' A' ' 347' ' ' LYS . 33.1 mm-40 -70.83 -31.5 68.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.555 -0.748 . . . . 1.88 111.431 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' ALA . . . . . 0.409 ' HA ' HD13 ' A' ' 296' ' ' ILE . . . -70.11 -32.24 70.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.98 0.419 . . . . 0.81 110.704 178.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -75.54 -28.58 59.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.042 -0.527 . . . . 1.7 110.328 175.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -66.0 -34.27 77.7 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.425 -0.807 . . . . 2.81 111.178 -176.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.8 t70 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.578 -0.725 . . . . 2.36 110.533 -179.809 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 . . . . . 0 N--CA 1.481 1.076 0 N-CA-C 110.049 -0.352 . . . . 8.22 110.049 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 62.18 31.42 17.65 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.681 0.753 . . . . 5.08 109.562 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ASP . . . . . 0.642 ' CB ' ' HD2' ' A' ' 283' ' ' PRO . 0.3 OUTLIER -109.36 -170.62 0.2 Allowed Pre-proline 0 CA--C 1.551 1.011 0 CA-C-O 117.258 -1.353 . . . . 5.71 108.998 -177.314 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . 0.642 ' HD2' ' CB ' ' A' ' 282' ' ' ASP . 20.5 Cg_exo -12.32 -63.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.377 2.066 1 C-N-CA 126.231 4.621 . . . . 4.3 118.006 -175.753 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' TRP . . . . . . . . . . . . . 17.2 p90 -56.65 -42.04 78.26 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.051 0.453 . . . . 5.85 111.283 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . 0.618 HH11 ' HB2' ' A' ' 285' ' ' ARG . 0.0 OUTLIER -65.01 -41.71 95.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.854 -0.612 . . . . 3.91 110.025 172.263 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' HIS . . . . . 0.431 ' HB3' ' O ' ' A' ' 283' ' ' PRO . 14.2 t-80 -56.46 -36.45 69.06 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.858 -1.065 . . . . 2.78 111.06 -173.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -54.16 -48.61 70.69 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.916 -0.401 . . . . 1.2 109.916 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -57.71 -39.1 76.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.593 -0.73 . . . . 1.73 111.636 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 38.3 mtt-85 -88.5 0.76 55.96 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.931 -0.577 . . . . 4.87 112.032 -176.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 61.7 m -122.39 -33.68 3.41 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.113 0.412 . . . . 2.73 112.113 -174.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -117.68 129.74 55.91 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.814 -0.355 . . . . 4.05 110.456 -176.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -75.77 132.23 40.3 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.879 -0.601 . . . . 4.31 110.262 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 65.3 mt -73.89 137.13 23.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.275 -0.42 . . . . 6.07 110.318 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 105.14 -7.98 44.67 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.852 -0.689 . . . . 2.84 112.861 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . 0.405 ' HG3' ' CG2' ' A' ' 297' ' ' VAL . 13.0 pt20 -85.85 152.17 23.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.036 0.446 . . . . 2.47 110.728 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.417 HG22 ' HB2' ' A' ' 345' ' ' MET . 2.3 mp -95.26 120.76 45.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.702 -0.681 . . . . 1.1 109.241 178.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.405 ' CG2' ' HG3' ' A' ' 295' ' ' GLN . 17.2 t -130.28 135.09 26.89 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.539 -0.301 . . . . 2.4 111.284 -173.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . 0.588 ' HA ' ' HA ' ' A' ' 345' ' ' MET . 24.3 Cg_exo -64.4 123.86 12.45 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.774 2.316 . . . . 2.52 111.791 173.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 343' ' ' ASP . . . -123.58 -175.2 14.4 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 111.095 -0.802 . . . . 1.77 111.095 176.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -127.23 111.83 14.4 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.607 0.242 . . . . 1.82 110.447 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 61.1 t -71.6 100.72 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.448 -0.575 . . . . 1.22 109.448 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . 0.49 ' O ' HG23 ' A' ' 340' ' ' VAL . 3.4 t -88.07 -44.02 11.26 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.951 -0.568 . . . . 0.73 110.796 -175.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 6.2 ttpp -129.53 160.87 31.87 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-O 120.769 0.318 . . . . 1.58 111.142 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.468 HD13 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -151.48 151.67 31.96 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.173 -0.467 . . . . 1.56 111.289 -179.075 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 1.5 m -150.41 154.89 36.34 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 108.714 -0.847 . . . . 0.88 108.714 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.18 -16.58 3.01 Favored 'Trans proline' 0 N--CA 1.479 0.629 0 C-N-CA 123.795 2.997 . . . . 0.76 115.319 -169.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -106.96 -16.98 14.31 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.554 0.575 . . . . 1.12 112.554 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . 0.573 ' HA2' ' O ' ' A' ' 321' ' ' VAL . . . -173.62 160.22 30.34 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.293 -0.956 . . . . 1.17 112.959 -176.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' ALA . . . . . 0.599 ' O ' ' HA ' ' A' ' 320' ' ' LEU . . . -123.39 149.06 45.45 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 117.161 0.48 . . . . 0.72 110.58 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' PHE . . . . . 0.424 ' CZ ' HD12 ' A' ' 320' ' ' LEU . 66.5 m-85 -105.21 117.19 33.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.08 0.467 . . . . 1.4 111.432 -176.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 3.0 p -104.39 134.96 44.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.686 -0.688 . . . . 1.37 110.253 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' ARG . . . . . 0.431 ' HD2' ' HG2' ' A' ' 318' ' ' GLU . 10.2 mmm180 -84.5 110.75 18.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.155 -0.475 . . . . 1.25 110.105 177.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.532 HG21 HD13 ' A' ' 358' ' ' ILE . 3.8 m -105.54 -42.88 7.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.924 0.392 . . . . 0.81 110.919 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -145.63 148.14 32.79 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.182 -1.044 . . . . 1.82 108.182 176.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -56.35 115.37 2.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.043 0.449 . . . . 2.69 111.637 -173.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 105.99 -19.48 37.95 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.65 -0.705 . . . . 0.95 113.166 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.444 HG23 HG23 ' A' ' 313' ' ' VAL . 6.2 tt -117.62 127.65 74.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.655 0.741 . . . . 1.23 111.339 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.431 ' HG2' ' HD2' ' A' ' 312' ' ' ARG . 43.8 mt-10 -123.44 133.17 54.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.248 -0.887 . . . . 1.51 110.363 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . 0.642 ' CA ' HG23 ' A' ' 358' ' ' ILE . . . -96.89 124.66 8.19 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.873 -0.68 . . . . 0.74 112.303 -175.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.599 ' HA ' ' O ' ' A' ' 309' ' ' ALA . 10.5 tt -91.09 132.35 36.1 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.572 -0.529 . . . . 2.04 109.572 178.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.573 ' O ' ' HA2' ' A' ' 308' ' ' GLY . 29.9 m -118.79 114.34 44.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.623 -0.51 . . . . 1.07 109.623 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -59.75 152.14 23.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.128 0.49 . . . . 2.41 110.502 -174.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 8.9 tp -53.12 -25.87 10.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.013 -0.994 . . . . 1.81 111.94 -177.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 42.4 t -82.89 -25.65 32.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.082 -0.508 . . . . 2.08 111.031 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -78.76 -10.93 59.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.15 0.5 . . . . 2.62 110.018 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 96.0 mt -79.95 -49.34 12.0 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.567 -0.742 . . . . 1.98 110.682 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -154.94 162.21 41.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.153 0.502 . . . . 2.32 111.208 -176.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -84.86 -12.87 52.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.218 -0.901 . . . . 3.31 110.737 -175.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' ARG . . . . . 0.523 ' HG2' ' N ' ' A' ' 330' ' ' HIS . 0.0 OUTLIER -105.19 176.59 5.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.118 -0.492 . . . . 2.17 110.683 -178.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' HIS . . . . . 0.523 ' N ' ' HG2' ' A' ' 329' ' ' ARG . 70.9 t60 -60.57 106.7 0.58 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.93 -0.577 . . . . 2.6 111.501 177.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' VAL . . . . . 0.404 HG22 ' CZ ' ' A' ' 329' ' ' ARG . 44.3 t -104.99 121.44 56.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.744 -0.835 . . . . 1.43 108.744 170.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -70.87 -59.25 2.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.538 0.685 . . . . 3.83 109.982 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 8.6 p -133.06 140.98 39.22 Favored Pre-proline 0 C--N 1.319 -0.733 0 N-CA-C 108.033 -1.099 . . . . 2.0 108.033 175.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -43.46 -25.08 0.72 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.925 3.084 . . . . 1.47 114.008 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -53.15 -30.19 35.66 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 123.777 0.673 . . . . 2.15 111.753 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -58.14 -40.14 80.59 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 120.955 0.407 . . . . 2.27 110.884 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 38.9 t -102.86 -45.5 10.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.024 -0.535 . . . . 2.07 110.344 -174.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.77 118.65 34.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.808 -0.633 . . . . 2.23 110.718 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -103.9 169.89 8.24 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.124 -0.489 . . . . 1.49 110.188 176.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 302' ' ' THR . 14.3 p -51.17 123.84 3.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.67 -0.695 . . . . 2.3 111.086 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 97.86 -2.43 60.13 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.619 -0.801 . . . . 1.86 112.917 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -65.74 131.49 46.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.818 0.342 . . . . 1.6 110.619 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 299' ' ' GLY . 11.9 t70 -107.57 103.6 12.96 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.275 -0.639 . . . . 2.03 109.275 178.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -132.09 140.25 48.78 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.685 0.279 . . . . 1.63 111.64 -173.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' MET . . . . . 0.588 ' HA ' ' HA ' ' A' ' 298' ' ' PRO . 0.2 OUTLIER -82.48 121.65 27.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.283 0.563 . . . . 3.05 110.307 175.182 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.54 153.68 35.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.468 -0.787 . . . . 1.43 109.484 -177.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . 0.42 ' HG2' HG23 ' A' ' 349' ' ' ILE . 1.3 ttmt -82.44 122.08 27.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.617 0.246 . . . . 1.98 110.627 178.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 66.8 t -72.83 105.84 2.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.114 -0.698 . . . . 1.57 109.114 172.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 359' ' ' SER . 9.9 pt -92.52 -24.79 5.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.078 -0.51 . . . . 0.97 111.323 -175.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -163.21 162.85 25.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.957 0.408 . . . . 1.44 110.938 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -137.06 122.26 25.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.457 -0.792 . . . . 1.45 109.298 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' ASP . . . . . 0.729 ' OD2' ' HD3' ' A' ' 355' ' ' ARG . 12.1 t0 -113.0 73.63 0.82 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.028 -0.73 . . . . 3.65 109.028 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . 0.449 HD22 ' C ' ' A' ' 353' ' ' LEU . 0.0 OUTLIER -72.71 -12.93 61.21 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.066 -0.97 . . . . 2.62 111.949 -170.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' GLU . . . . . 0.601 ' C ' ' HD2' ' A' ' 355' ' ' ARG . 41.0 mt-10 -87.66 -13.34 42.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.814 0.34 . . . . 3.8 110.808 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' ARG . . . . . 0.729 ' HD3' ' OD2' ' A' ' 352' ' ' ASP . 5.8 mpt_? -116.46 2.5 13.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.672 0.749 . . . . 3.45 109.103 174.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . 0.611 HH11 ' HG2' ' A' ' 356' ' ' ARG . 5.5 mmt-85 61.26 43.09 11.2 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 114.19 -1.368 . . . . 3.1 111.09 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' ARG . . . . . 0.441 ' HB2' ' HB3' ' A' ' 352' ' ' ASP . 53.3 mtp180 -125.43 157.52 36.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.779 -0.646 . . . . 2.52 110.423 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.642 HG23 ' CA ' ' A' ' 319' ' ' GLY . 5.0 tt -141.07 143.71 27.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.588 -0.523 . . . . 1.93 109.588 174.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.432 ' O ' HG12 ' A' ' 349' ' ' ILE . 55.9 m -113.75 135.65 53.72 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.425 -0.352 . . . . 0.84 111.164 -174.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.478 ' O ' HG12 ' A' ' 321' ' ' VAL . 4.3 mp -145.13 155.46 43.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.237 -0.438 . . . . 1.15 110.08 178.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 44.3 m -143.09 129.63 20.16 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.962 0.41 . . . . 1.33 110.843 176.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.08 -27.45 66.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.946 -0.57 . . . . 1.96 110.617 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' LYS . . . . . 0.423 ' H ' ' HG2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -60.48 -52.8 63.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.305 0.574 . . . . 1.17 109.837 -179.607 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.512 ' HA ' ' HB3' ' A' ' 367' ' ' GLU . 47.7 mt-30 -70.99 -28.09 64.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.229 -0.896 . . . . 1.88 111.47 -178.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -61.07 -41.04 95.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.028 0.442 . . . . 0.81 110.558 175.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -78.16 -29.39 48.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.98 -0.555 . . . . 1.7 110.342 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . 0.512 ' HB3' ' HA ' ' A' ' 364' ' ' GLN . 36.5 tt0 -66.99 -44.0 81.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.378 -0.828 . . . . 2.81 111.49 -178.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.715 -0.66 . . . . 2.36 110.954 -178.575 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 121.443 0.639 . . . . 8.22 110.016 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 286' ' ' HIS . 39.2 mt-10 -100.47 84.21 2.74 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.968 -0.56 . . . . 5.08 109.748 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -63.85 151.19 89.74 Favored Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 115.387 -0.824 . . . . 5.71 111.302 -176.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -27.84 -62.73 0.08 OUTLIER 'Trans proline' 0 C--N 1.354 0.83 1 C-N-CA 125.513 4.142 . . . . 4.3 115.615 -175.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' TRP . . . . . . . . . . . . . 14.4 p90 -56.19 -43.88 78.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.124 0.487 . . . . 5.85 112.121 -177.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . 0.432 ' HD2' ' HA ' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -81.43 -27.81 34.52 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.433 0.635 . . . . 3.91 110.072 -178.779 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' HIS . . . . . 0.461 ' HB2' ' O ' ' A' ' 281' ' ' GLU . 74.0 t60 -66.74 -46.05 76.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.408 -0.815 . . . . 2.78 110.228 175.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -54.03 -48.61 70.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.088 -0.505 . . . . 1.2 110.632 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -54.63 -41.47 70.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.779 -0.646 . . . . 1.73 112.276 -175.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -91.31 -19.75 22.62 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.455 0.539 . . . . 4.87 112.455 -177.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 91.7 m -90.43 -31.43 16.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.933 0.397 . . . . 2.73 111.644 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -115.28 163.5 15.59 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.67 0.271 . . . . 4.05 110.521 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -96.96 121.29 38.68 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.14 -0.482 . . . . 4.31 110.977 -175.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 73.8 mt -65.72 119.87 11.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.244 -0.434 . . . . 6.07 109.903 176.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 101.4 7.81 48.15 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.65 -0.786 . . . . 2.84 112.154 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -80.94 147.26 30.36 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.991 0.424 . . . . 2.47 110.178 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.416 HG12 ' HB2' ' A' ' 347' ' ' LYS . 67.0 mt -95.65 110.35 24.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.919 -0.771 . . . . 1.1 108.919 172.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 3.4 p -132.42 136.65 28.35 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 116.136 -0.484 . . . . 2.4 110.756 -172.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . 0.568 ' HA ' ' HA ' ' A' ' 345' ' ' MET . 17.7 Cg_endo -58.57 122.05 10.99 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.677 2.251 . . . . 2.52 112.274 177.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.474 ' HA3' ' CG1' ' A' ' 311' ' ' VAL . . . -110.97 -170.33 19.26 Favored Glycine 0 N--CA 1.438 -1.189 0 N-CA-C 111.0 -0.84 . . . . 1.77 111.0 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.455 ' HE3' ' HA2' ' A' ' 341' ' ' GLY . 1.9 tmtm? -152.31 112.48 4.05 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.907 0.384 . . . . 1.82 109.979 -175.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 60.3 t -70.74 100.48 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.896 -0.593 . . . . 1.22 110.554 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 1.8 t -95.38 -16.15 22.55 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.102 0.477 . . . . 0.73 110.829 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . 0.423 ' HB3' ' HE3' ' A' ' 303' ' ' LYS . 3.1 mmmt -154.98 141.12 18.46 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.848 -0.615 . . . . 1.58 109.997 -178.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.488 HD13 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -134.86 140.19 45.62 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.163 -0.615 . . . . 1.56 110.791 173.646 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 27.3 m -132.17 162.78 54.67 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.324 -0.853 . . . . 0.88 109.295 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -49.36 -31.32 22.69 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.428 2.085 . . . . 0.76 114.166 -173.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -109.75 18.07 20.58 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.949 0.722 . . . . 1.12 112.949 -175.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . 0.575 ' HA2' ' O ' ' A' ' 321' ' ' VAL . . . 162.57 160.35 11.08 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 119.069 -1.539 . . . . 1.17 114.342 176.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' ALA . . . . . 0.526 ' HB3' HG22 ' A' ' 321' ' ' VAL . . . -114.45 123.35 49.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.542 0.211 . . . . 0.72 110.484 178.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -76.72 108.91 10.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.43 0.633 . . . . 1.4 111.529 -176.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.474 ' CG1' ' HA3' ' A' ' 299' ' ' GLY . 88.5 t -92.73 116.27 33.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 114.986 -1.006 . . . . 1.37 110.871 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' ARG . . . . . 0.447 ' NH2' ' HA ' ' A' ' 315' ' ' GLU . 13.1 tpt180 -75.97 117.19 17.43 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.359 -0.837 . . . . 1.25 109.688 175.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.532 HG21 HD13 ' A' ' 358' ' ' ILE . 4.8 m -119.04 -35.73 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.866 0.365 . . . . 0.81 111.786 -178.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -148.95 155.74 41.27 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.567 -0.531 . . . . 1.82 109.567 -176.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' GLU . . . . . 0.447 ' HA ' ' NH2' ' A' ' 312' ' ' ARG . 10.0 tp10 -58.22 113.24 1.84 Allowed 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.536 0.522 . . . . 2.69 110.619 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 105.65 -11.3 46.19 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.75 -0.738 . . . . 0.95 113.404 177.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 8.1 tt -130.0 124.86 59.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 117.925 0.863 . . . . 1.23 113.243 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -126.35 136.93 53.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.689 -1.141 . . . . 1.51 108.662 170.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . 0.533 ' HA3' ' O ' ' A' ' 358' ' ' ILE . . . -130.97 138.64 10.32 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.129 -1.034 . . . . 0.74 112.772 -176.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.489 ' HA ' ' O ' ' A' ' 309' ' ' ALA . 0.0 OUTLIER -80.55 144.31 32.55 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.014 0.435 . . . . 2.04 111.223 -177.767 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.575 ' O ' ' HA2' ' A' ' 308' ' ' GLY . 29.3 m -98.0 138.6 22.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.469 -0.937 . . . . 1.07 108.469 172.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -59.27 147.73 34.61 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.947 0.403 . . . . 2.41 110.981 -173.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.562 HD13 ' O ' ' A' ' 323' ' ' ILE . 0.0 OUTLIER -61.31 -21.48 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 115.845 -0.616 . . . . 1.81 110.095 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 5.1 m -69.76 -20.41 63.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.799 -0.637 . . . . 2.08 110.555 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' GLU . . . . . 0.686 ' OE1' ' HG2' ' A' ' 363' ' ' LYS . 65.7 mm-40 -69.78 -15.38 63.11 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.898 -0.592 . . . . 2.62 110.513 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.488 HD12 HG12 ' A' ' 323' ' ' ILE . 49.2 mt -86.67 33.88 0.65 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.622 -0.717 . . . . 1.98 110.651 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 326' ' ' LEU . . . 74.77 -175.38 0.14 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.125 -0.943 . . . . 2.32 110.56 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -94.02 -0.57 55.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.066 0.46 . . . . 3.31 110.891 -171.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' ARG . . . . . 0.465 ' CZ ' HG22 ' A' ' 331' ' ' VAL . 11.5 ptt85 -84.2 -179.71 7.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.203 0.525 . . . . 2.17 111.198 -177.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -82.51 112.99 19.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.421 -0.809 . . . . 2.6 110.35 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' VAL . . . . . 0.532 HG13 HE21 ' A' ' 336' ' ' GLN . 48.1 t -129.02 123.31 58.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.094 0.474 . . . . 1.43 110.894 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -71.45 -36.09 71.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.636 -0.711 . . . . 3.83 111.712 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.46 HG22 ' H ' ' A' ' 335' ' ' ASP . 7.1 p -160.76 139.64 7.66 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.694 -0.684 . . . . 2.0 109.34 -175.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -44.46 -23.69 0.86 Allowed 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 124.121 3.214 . . . . 1.47 113.721 177.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.46 ' H ' HG22 ' A' ' 333' ' ' VAL . 30.2 t70 -60.67 -21.29 62.66 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 123.64 0.588 . . . . 2.15 111.579 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . 0.532 HE21 HG13 ' A' ' 331' ' ' VAL . 10.6 mt-30 -66.48 -32.79 74.38 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.037 0.446 . . . . 2.27 110.62 176.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 52.0 t -103.09 -54.51 6.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.896 -0.593 . . . . 2.07 110.673 -173.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 335' ' ' ASP . 33.0 m -116.83 161.76 15.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.896 -0.593 . . . . 2.23 110.251 -178.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -124.88 168.4 13.32 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.098 0.475 . . . . 1.49 110.482 177.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 8.2 p -57.25 134.35 21.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.207 -0.906 . . . . 2.3 109.857 174.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . 0.455 ' HA2' ' HE3' ' A' ' 300' ' ' LYS . . . 100.49 -2.47 56.1 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.491 -0.861 . . . . 1.86 112.869 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' A' ' 300' ' ' LYS . 9.0 t70 -70.39 124.62 24.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.817 0.342 . . . . 1.6 110.977 -179.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -110.33 113.63 26.44 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.363 -0.606 . . . . 2.03 109.363 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -146.58 150.36 35.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.521 0.2 . . . . 1.63 111.157 -175.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' MET . . . . . 0.568 ' HA ' ' HA ' ' A' ' 298' ' ' PRO . 18.2 ptm -78.79 120.16 23.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.26 0.552 . . . . 3.05 110.517 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.59 151.7 34.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.705 -0.679 . . . . 1.43 109.641 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 360' ' ' LEU . 1.8 ttmt -88.52 125.73 34.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.609 0.242 . . . . 1.98 111.181 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 87.0 t -74.71 101.11 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.824 -0.625 . . . . 1.57 109.455 173.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' ILE . . . . . 0.491 HG12 ' O ' ' A' ' 359' ' ' SER . 6.0 pt -92.53 -20.53 6.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.964 -0.562 . . . . 0.97 111.267 -174.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' ASP . . . . . 0.407 ' HB3' ' HB2' ' A' ' 359' ' ' SER . 2.7 t70 -161.89 161.77 28.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.921 0.391 . . . . 1.44 110.717 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 1.3 mm -137.04 117.18 16.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.338 -0.846 . . . . 1.45 109.335 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' ASP . . . . . 0.51 ' HB3' ' HB2' ' A' ' 355' ' ' ARG . 12.1 m-20 -83.59 96.35 8.62 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.296 0.57 . . . . 3.65 109.935 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . 0.423 HD13 ' C ' ' A' ' 353' ' ' LEU . 3.4 tm? -57.1 -51.87 67.57 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.423 -1.262 . . . . 2.62 110.83 -176.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -90.89 -14.2 32.16 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.062 0.764 . . . . 3.8 113.062 -174.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' ARG . . . . . 0.51 ' HB2' ' HB3' ' A' ' 352' ' ' ASP . 2.2 mpt_? -100.04 -1.13 37.73 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.062 -0.655 . . . . 3.45 110.699 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . 0.645 ' HD2' ' N ' ' A' ' 356' ' ' ARG . 2.6 mpt_? 52.89 45.97 27.7 Favored 'General case' 0 C--N 1.335 -0.064 0 CA-C-N 115.008 -0.996 . . . . 3.1 111.33 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 30.8 mtp180 -130.51 169.07 16.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.683 -0.689 . . . . 2.52 110.103 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.533 ' O ' ' HA3' ' A' ' 319' ' ' GLY . 6.5 tt -140.54 136.65 36.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.719 -0.474 . . . . 1.93 109.719 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.491 ' O ' HG12 ' A' ' 349' ' ' ILE . 66.8 m -102.49 130.94 49.45 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.476 -0.329 . . . . 0.84 110.558 -177.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.514 ' HA ' ' O ' ' A' ' 347' ' ' LYS . 3.3 mp -139.65 145.51 38.54 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.344 -0.389 . . . . 1.15 110.369 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 53.9 m -131.88 126.78 35.03 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.308 0.575 . . . . 1.33 111.06 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 52.3 mt -68.78 -27.47 65.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.242 -0.89 . . . . 1.96 110.759 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' LYS . . . . . 0.686 ' HG2' ' OE1' ' A' ' 325' ' ' GLU . 0.0 OUTLIER -58.86 -44.98 91.17 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.061 0.457 . . . . 1.17 109.865 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.483 ' HB3' ' HD2' ' A' ' 347' ' ' LYS . 33.1 mm-40 -70.83 -31.5 68.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.555 -0.748 . . . . 1.88 111.431 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' ALA . . . . . 0.409 ' HA ' HD13 ' A' ' 296' ' ' ILE . . . -70.11 -32.24 70.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.98 0.419 . . . . 0.81 110.704 178.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -75.54 -28.58 59.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.042 -0.527 . . . . 1.7 110.328 175.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -66.0 -34.27 77.7 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.425 -0.807 . . . . 2.81 111.178 -176.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.8 t70 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.578 -0.725 . . . . 2.36 110.533 -179.809 . . . . . . . . 0 0 . 1 stop_ save_